Evo Payments Inc (EVOP)
May 23, 2018
See more details
Kiniksa Pharmaceuticals (KNSA)
May 24, 2018
See more details
Scholar Rock Holdings (SRRK US)
May 24, 2018
See more details
GreenSky Inc (GSKY)
May 24, 2018
See more details
Iterum Therapeutics (ITRM US)
May 25, 2018
See more details
M17 Entertainment Ltd (YQ US)
June 7, 2018
See more details
MeiraGTx Holdings (MGTX US)
June 8, 2018
See more details
US Xpress Enterprises Inc (USX US)
June 14, 2018
See more details
Charah Solutions Inc (CHRA US)
June 14, 2018
See more details
WITHDRAWN Adaptive Insights Inc (ADIN US)
June 14, 2018
See more details
Avalara Inc (AVLR US)
June 15, 2018
See more details
Puxin Ltd (NEW US)
June 15, 2018
See more details
Verrica Pharmaceuticals (VRCA US)
June 15, 2018
See more details
Eidos Therapeutics (EIDX US)
June 20, 2018
See more details
Avrobio Inc (AVRO US)
June 21, 2018
See more details
Kezar Life Science Inc (KZR US)
June 21, 2018
See more details
Aptinyx Inc (APTX US)
June 21, 2018
See more details
Essential Properties Realty Trust (EPRT US)
June 21, 2018
See more details
ElectroCore LLC (ECOR US)
June 21, 2018
See more details
I3 Verticals Inc (IIIV US)
June 21, 2018
See more details
Magenta Therapeutics (MGTA US)
June 21, 2018
See more details
Xeris Pharmaceuticals (XERS US)
June 21, 2018
See more details
Autolus Therapeutics Ltd (AUTL US)
June 22, 2018
See more details
Neon Therapeutics (NTGN US)
June 27, 2018
See more details
Uxin Ltd (UXIN US)
June 27, 2018
See more details
EverQuote (EVER US)
June 28, 2018
See more details
Translate Bio (TBIO US)
June 28, 2018
See more details
Goodbulk (GBLK US)
June 28, 2018
See more details
Tricida (TCDA US)
June 28, 2018
See more details
BrightView (BV US)
June 28, 2018
See more details
Forty Seven (FTSV US)
June 28, 2018
See more details
Neuronetics (STIM US)
June 28, 2018
See more details
BJ's Wholesale Club (BJ US)
June 28, 2018
See more details
Domo Inc (DOMO US)
June 29, 2018
See more details
Demo with Pete, Chaikin System
July 2, 2018 9:30 am - 10:30 am
See more details
Rubius Therapeutics (RUBY US)
July 18, 2018
See more details
Coastal Financial Corp (CCB US)
July 18, 2018
See more details
Crinetics Pharmaceuticals (CRNX US)
July 18, 2018
See more details
Establishment Labs Holdings (ESTA US)
July 19, 2018
See more details
Tilray (TLRY US)
July 19, 2018
See more details
AFG Holdings (AFGL US) POSTPONED
July 19, 2018
See more details
Allakos (ALLK US)
July 19, 2018
See more details
Constellation Pharmaceuticals (CNST US)
July 19, 2018
See more details
First Western Financial (MYFW US)
July 19, 2018
See more details
Replimune Group (REPL US)
July 20, 2018
See more details
Provention Bio (PRVB US), Priced on 07/19/2018
July 24, 2018
See more details
Aquestive Therapeutics (AQST US)
July 25, 2018
See more details
Bloom Energy (BE US)
July 25, 2018
See more details
Berry Petroleum (BRRP US) from OTC to NASDAQ
July 26, 2018
See more details
Tenable Holdings (TENB US)
July 26, 2018
See more details
Linquidia Technologies (LQDA US)
July 26, 2018
See more details
Endava PLC (DAVA US)
July 26, 2018
See more details
Aurora Mobile (JG US)
July 26, 2018
See more details
Focus Financial Partners (FOCS US)
July 26, 2018
See more details
Cango Inc (CANG US)
July 26, 2018
See more details
Pinduoduo (PDD US)
July 26, 2018
See more details
Opera Ltd (OPRA US)
July 27, 2018
See more details
Sonos Inc (SONO US)
August 2, 2018
See more details
Cushman & Wakefield PLC (CWK US)
August 2, 2018
See more details
Arlo Technologies (ARLO US)
August 3, 2018
See more details
Meeting with Kent
August 8, 2018 9:00 am - 10:00 am
See more details
Mesa Air Group (MESA US)
August 9, 2018
See more details
Amalgamated Bank (ANYB US)
August 9, 2018
See more details
Vaccinex Inc (VCNX US)
August 9, 2018
See more details
111 Inc (YI US)
September 12, 2018
See more details
Principia Biopharma Inc (PRNB US)
September 14, 2018
See more details
Navios Maritime Containers (NMCI US)
September 14, 2018
See more details
Qutoutiao (QTT US)
September 14, 2018
See more details
X Financial (XYF US)
September 19, 2018
See more details
Bank7 Corp (BSVN US)
September 20, 2018
See more details
Remora Royalties (RRI US)
September 21, 2018
See more details
Viomi Technology (VIOT US)
September 25, 2018
See more details
Entasis Therapeutics (ETTX US)
September 26, 2018
See more details
Capital Bancorp (CBNK US)
September 26, 2018
See more details
SurveyMonkey Inc (SVMK US)
September 26, 2018
See more details
CooTek Cayman Inc (CTK US)
September 26, 2018
See more details
Ra Medical Systems (RMED US)
September 27, 2018
See more details
Kodiak Sciences (KOD US)
October 4, 2018
See more details
Osmotica Pharmaceuticals (OSMT US)* Postponed
October 11, 2018
See more details
Equillium (EQ US)
October 12, 2018
See more details
Riley Exploration-Permian (REPX US) - NYSEAmerican* Postponed
October 17, 2018
See more details
SI-BONE (SIBN US)* (upsized)
October 17, 2018
See more details
Osmotica Pharmaceutical (OSMT US)*
October 18, 2018
original price range between $14-16, set at $7
See more details
Studio City International (MSC US)
October 18, 2018
See more details
Niu Technology (NIU US)
October 19, 2018
See more details
LogicBio Therapeutics (LOGC US)
October 19, 2018
See more details
Alzheon (ALZH US)* (most likely canceled again)
October 24, 2018
See more details
Gamida Cell Ltd (GMDA US)
October 26, 2018
See more details
Axonics Mudolation Technologies (AXNX US)
November 1, 2018
See more details
CNFinance (CNF US)
November 6, 2018
See more details
Vapotherm (VAPO US)
November 14, 2018
See more details
Weidai (WEI US)
November 15, 2018
See more details
Centrexion Therapeutics (CNTX US)
November 15, 2018
See more details
Autonomous Control Systems Laboratory
December 21, 2018
Tokyo Stock Exchange
6232 JP
See more details
New Fortress Energy (TRADING)
January 31, 2019
NASDAQ Global Select
NFE US Postponed on Jan 25th
See more details
BankFlorida (POSTPONED)
February 11, 2019
Postponed
BFL US
$9.50 - $10.50/share
Offer Size: 4.2 million ~81.80% float
BankFlorida, formerly FirstCity Bank of Commerce, is a Florida state-charted community bank based in Palm Beach Gardens, Florida. The bank provides general commercial and personal banking services, especially to SMEs.
See more details
Chunbo (TRADING)
February 11, 2019
KOSDAQ
278280 KS
40,000 won/share, high-end of its expected price range of ₩35,000 - ₩40,000/share
Shares: 2.5 million
Established in 2007, Chunbo is a fine chemical material provider in Korea. The company manufactures and supplies specialized chemical to industries including LCD, semiconductor, pharmaceutical etc.
40,000 won/share, high-end of its expected price range of ₩35,000 - ₩40,000/share
Shares: 2.5 million
Established in 2007, Chunbo is a fine chemical material provider in Korea. The company manufactures and supplies specialized chemical to industries including LCD, semiconductor, pharmaceutical etc.
See more details
Sequana Medical (TRADING)
February 11, 2019
Brussels Stock Exchange
SEQUA BB
€8.5/share, lower end of its indicative price range €8.50 - €9.00/share
Shares: 3,235,294 shares, ~24.7% float
Sequana Medical is a commercial stage medical device company headquartered in Ghent, Belgium established in 2005. Sequana develops medical devices for liver disease, heard failure, malignant ascites and other fluid imbalance disorders. The company has one commercialized product, the alfapump, which pumps out the ascites and help the body to eliminates ascites naturally. The product has not yet received regulatory approval in the U.S. but has received approval in EU. Existing shareholders have irrevocably committed to subscribe €20.5 million in the offering, i.e. 74.55% of the offering.
https://www.sequanamedical.com/
€8.5/share, lower end of its indicative price range €8.50 - €9.00/share
Shares: 3,235,294 shares, ~24.7% float
Sequana Medical is a commercial stage medical device company headquartered in Ghent, Belgium established in 2005. Sequana develops medical devices for liver disease, heard failure, malignant ascites and other fluid imbalance disorders. The company has one commercialized product, the alfapump, which pumps out the ascites and help the body to eliminates ascites naturally. The product has not yet received regulatory approval in the U.S. but has received approval in EU. Existing shareholders have irrevocably committed to subscribe €20.5 million in the offering, i.e. 74.55% of the offering.
https://www.sequanamedical.com/
See more details
Anchiano Therapeutics (TRADING)
February 12, 2019
Nasdaq Capital Market
ANCN US (ADS)
Fixed price at $14.55/ADS (based on the last reported sale price on TASE on 1/28/2019)
Shares: 2.4 million ADSs (representing 12 million ordinary shares), ~36.5% float
Anchiano is an Israeli clinical-stage gene therapy company focused on treatment for early-stage bladder cancer. The lead product candidate has showed potential to delay and (in some cases) eliminate early bladder cancer progression in Phase 1/2 clinical trials. The company commenced operation in 2004 and had a trading history on TASE under the name BioCancell (BICL IT) since 2012. Exiting shareholders have indicated an interest in purchasing up to $17.5 million of the ADSs at offer (~50% of initial offering size).
https://www.anchiano.com/
Fixed price at $14.55/ADS (based on the last reported sale price on TASE on 1/28/2019)
Shares: 2.4 million ADSs (representing 12 million ordinary shares), ~36.5% float
Anchiano is an Israeli clinical-stage gene therapy company focused on treatment for early-stage bladder cancer. The lead product candidate has showed potential to delay and (in some cases) eliminate early bladder cancer progression in Phase 1/2 clinical trials. The company commenced operation in 2004 and had a trading history on TASE under the name BioCancell (BICL IT) since 2012. Exiting shareholders have indicated an interest in purchasing up to $17.5 million of the ADSs at offer (~50% of initial offering size).
https://www.anchiano.com/
See more details
Virgin Trains USA (WITHDRAWN)
February 13, 2019
Nasdaq
Withdrawn
VTUS US
$17.00 - $19.00/share
Shares: 28,334,000 shares, ~17.1% float
Virgin Trains USA Inc is a private equity funds backed railroad operator and commenced service in 2018. The company was formed in 2013 under AAF Holdings and partnered up with Virgin Enterprises Limited (VEL) in November 16 2018 to re-brand its originally Brightline to Virgin Trains USA. The company owns and operates an express passenger intercity rail system between Miami and West Palm Beach, Florida. Virgin Trains acquired XpressWest in September 2018 to expand operation to California and Las Vegas and is expected to close the $120 million acquisition in Q1 2019. Fortress Fund will hold ~81.6% of the common stock. Corvina Holdings (affiliate of Virgin Enterprises Limited) has agreed to purchase up to 2% of the number of shares outstanding. The company has a valuation of $3.15 billion on high-end yet only has a $5.2 million sales for the first nine months of operation in 2018.
See more details
ESCON Japan REIT Investment (TRADING)
February 13, 2019
Tokyo Stock Exchange
2971 JP
Priced at 101,000 yen/share
Offer Size: 19.03 billion yen (approximately $172.80 million)
Established in 2016, ESCON Japan REIT Investment Corporation (EJR) is the subsidiary of ES-CON Asset Management, the real estate investment advisory arm of the 1995 Osaka-based real estate veteran ES CON Japan. The REIT portfolio includes local area shopping center and leasehold land in Osaka and Okayama.
https://www.esconam.jp/en/
Priced at 101,000 yen/share
Offer Size: 19.03 billion yen (approximately $172.80 million)
Established in 2016, ESCON Japan REIT Investment Corporation (EJR) is the subsidiary of ES-CON Asset Management, the real estate investment advisory arm of the 1995 Osaka-based real estate veteran ES CON Japan. The REIT portfolio includes local area shopping center and leasehold land in Osaka and Okayama.
https://www.esconam.jp/en/
See more details
Avedro (TRADING)
February 14, 2019
Nasdaq Global Market
AVDR US
$14.00 - $16.00/share
Shares: 5 million shares ~29.3% float
Avedro is a commercial-stage ophthalmic medical device company. First incorporated under the name ThermalVision in 2002, the Waltham, MA-based company has an FDA approved treatment of progressive keratoconus and corneal ectasia following refractive surgery launched in 2016 and product for vision correction procedures in EU. The small-cap company had raised $218.5 million in previous private funding and has a ~9.9 P/S ratio.
http://avedro.com/location/
$14.00 - $16.00/share
Shares: 5 million shares ~29.3% float
Avedro is a commercial-stage ophthalmic medical device company. First incorporated under the name ThermalVision in 2002, the Waltham, MA-based company has an FDA approved treatment of progressive keratoconus and corneal ectasia following refractive surgery launched in 2016 and product for vision correction procedures in EU. The small-cap company had raised $218.5 million in previous private funding and has a ~9.9 P/S ratio.
http://avedro.com/location/
See more details
TCR2 Therapeutics (TRADING)
February 14, 2019
Nasdaq Global Market
TCRR US
$14.00 - $16.00/share
Shares: 5 million shares, ~21.56% float
TCR2 Therapeutics is a PE-backed early clinical-stage immunotherapy company commenced operation in 2015. The Cambridge MA-based company specializes in T cell therapies for cancer. The IND of its lead product candidate was just cleared by FDA. There are total of 5 product candidates in TCR2's pipeline target either solid tumors or hematological malignancies, with the most advanced program in preparation of Phase 1/2 clinical trial and the rest either in IND application process or still in discovery stage. The company has license agreement with Harpoon Therapeutics (HARP US), which was listed on Nasdaq a week ago. Certain existing stockholders have indicated an interest in purchasing approximately $30 million of shares in this offering, i.e. ~37.5% of this offering.
$14.00 - $16.00/share
Shares: 5 million shares, ~21.56% float
TCR2 Therapeutics is a PE-backed early clinical-stage immunotherapy company commenced operation in 2015. The Cambridge MA-based company specializes in T cell therapies for cancer. The IND of its lead product candidate was just cleared by FDA. There are total of 5 product candidates in TCR2's pipeline target either solid tumors or hematological malignancies, with the most advanced program in preparation of Phase 1/2 clinical trial and the rest either in IND application process or still in discovery stage. The company has license agreement with Harpoon Therapeutics (HARP US), which was listed on Nasdaq a week ago. Certain existing stockholders have indicated an interest in purchasing approximately $30 million of shares in this offering, i.e. ~37.5% of this offering.
See more details
Cibus Global (POSTPONED)
February 14, 2019
Nasdaq
Postponed
CBUS US
$14.00 - $16.00/share
Shares: 6,666,667 shares ~28.6% float
Cibus Global is a biotech x agricultural company founded in 2001. Based in San Diego, CA, the company use non-transgenic gene-editing technology, the Rapid Trait Developement System (RTDS), to edit plant (crops) genes. The company generates revenue from the sales of sulfonylurea-tolerant canola seeds (SU Canola) in North America, collaboration and research, and license plant traits to leading seed companies. Cibus established partnerships with food processing companies Cargill and Bunge to promote their canola seed sales. Fidelity Investments will be holding ~6% of the shares after the offering.
https://www.cibus.com/
See more details
Stealth BioTherapeutics (TRADING)
February 15, 2019
Nasdaq Global Market
MITO US (ADR)
$12.00 - $14.00/share
Shares: 6.2 million ADSs, representing 74.4 million shares, ~18.78% float
Stealth BioTherapeutics is a clinical-stage biotech company began operation in 2006 with executive office located in Newton, MA. The company focuses on mitochondrial medicine. Stealth has 2 clinical-stage product candidates in its development pipeline with the lead indicator for Primary Mitochondrial Myopathy in Phase 3 clinical trial, and for Barth Syndrom in discussion of NDA submission. Existing principle shareholder has indicated an interest in purchasing up to $60 million of ADS in this offering, i.e. ~75% of the offering.
www.stealthbt.com
$12.00 - $14.00/share
Shares: 6.2 million ADSs, representing 74.4 million shares, ~18.78% float
Stealth BioTherapeutics is a clinical-stage biotech company began operation in 2006 with executive office located in Newton, MA. The company focuses on mitochondrial medicine. Stealth has 2 clinical-stage product candidates in its development pipeline with the lead indicator for Primary Mitochondrial Myopathy in Phase 3 clinical trial, and for Barth Syndrom in discussion of NDA submission. Existing principle shareholder has indicated an interest in purchasing up to $60 million of ADS in this offering, i.e. ~75% of the offering.
www.stealthbt.com
See more details
BMIT Technologies (TRADING)
February 18, 2019
Valletta
BMIT MV
€0.49/share
Offer Shares: 99,761,701 shares (79,261,701 shares have been allocated amongst financial intermediaries)
Registered in 2009 as GO Data Centre Services in Malta, BMIT Technologies provides data center services in Malta. The company owns and operates private international managed network, provides cloud services and other IT solutions. Go p.l.c. will hold a minimum of 51% of the issued share of BMIT following the offering. P/S ratio is ~4.66x based on projected revenue.
€0.49/share
Offer Shares: 99,761,701 shares (79,261,701 shares have been allocated amongst financial intermediaries)
Registered in 2009 as GO Data Centre Services in Malta, BMIT Technologies provides data center services in Malta. The company owns and operates private international managed network, provides cloud services and other IT solutions. Go p.l.c. will hold a minimum of 51% of the issued share of BMIT following the offering. P/S ratio is ~4.66x based on projected revenue.
See more details
Zen Corp Group (TRADING)
February 20, 2019
Bangkok
ZEN TB
Thai Baht 13.00/share
Shares: 75.00 million shares
Thai Baht 13.00/share
Shares: 75.00 million shares
See more details
Cellid (TRADING)
February 20, 2019
KOSDAQ
299660 KS
33,000 won/share, above 25,000 - 31,000/share range
Shares 1.20 million shares
33,000 won/share, above 25,000 - 31,000/share range
Shares 1.20 million shares
See more details
Gear 1 Spa (TRADING)
February 26, 2019
Borsa Italiana
GEA IM
€10/share
Offer: 3 million shares
€10/share
Offer: 3 million shares
See more details
CStone Pharmaceuticals (TRADING)
February 26, 2019
Hong Kong Stock Exchange
2616 HK
Priced at HK$12.00/share, little above midpoint of its HK$11.10 - 12.80/share expected range
Shares: 186,396,000 shares ~18.94% float
CStone Pharmaceuticals is a Chinese clinical-staged biopharmaceutical company focused on immuno-oncology. The company is currently working on 14 product candidates in its pipeline from pre-clinical stage to late-stage with partners like Agios and Blueprint. The most advanced drug candidate treating relapsed or refractory AML with Agios. CStone was founded by WuXi Healthcare Ventures, incorproated in 2015 and started research and development operation in 2016. CStone is said to priced at the upper-half of the range and raised HK$2.24 billion. The VC fund will continue to be the largest shareholders after the Listing with ~29.76% shares. Cornerstone investors, including existing shareholders have agreed to subscribe approximately 1/3 of the offer shares.
See more details
Super League Gaming (TRADING)
February 26, 2019
NASDAQ CM
SLGG US
$10.00 - $12.00/share
Shares: 2,272,727 shares, ~27.26% float
Super League Gaming operates a gaming platform that connects amateur esports gamers, venues, game publishers and brand partners. Founded in 2014 as Nth Games, Inc, the CA-based company established league teams in Minecraft, League of Legends, Clash Royale and Fortnite. Super League Gaming generates revenues from advertising and sponsorship as well as subscriptions and event holding. Sales has grown 420% from 2017 to 2018 yet the company only generates ~1 million in sales.
The final offer price was set at $11/share
$10.00 - $12.00/share
Shares: 2,272,727 shares, ~27.26% float
Super League Gaming operates a gaming platform that connects amateur esports gamers, venues, game publishers and brand partners. Founded in 2014 as Nth Games, Inc, the CA-based company established league teams in Minecraft, League of Legends, Clash Royale and Fortnite. Super League Gaming generates revenues from advertising and sponsorship as well as subscriptions and event holding. Sales has grown 420% from 2017 to 2018 yet the company only generates ~1 million in sales.
The final offer price was set at $11/share
See more details
Dexin China (TRADING)
February 26, 2019
Hong Kong Stock Exchange
2019 HK
HK$2.32 - 3.25/share
Shares: 532,000,000 shares, ~20.21% float
Dexin is a comprehensive property developer in Zhejiang Province, China. The company focuses primarily on the development and sales of residential properties and the development, operation and management of commercial and mixed-use properties. Dexin was founded in 1995. Revenue of Dexin can be breakdown by property (residential, car parks, & commercial spaces) development and sales (99.3%), property construction services and project management services (0.2%), property leasing (0.3%) and hotel operations (0.2%). Several cornerstone investors has entered the agreement to subscribe the IPO.
The final offer price was set at HK$2.80/share.
See more details
Kaleido Biosciences (TRADING)
February 28, 2019
KLDO US
$20.00 - $22.00/share ***Priced at $15.00/share***
Shares: 4,761,905 shares ~16.2% float ***Upsize to offer 5 million shares***
Kaleido Biosciences is a Massachusetts-based, early clinical-stage microbiome metabolic therapies (MMT) company founded in 2015. The company has conducted several non-IND human clinical studies with its most advanced product candidates in the pipeline under potential IND Filing stage and intend to initiate a Phase 2 clinical trial in first half of 2019. Lead product candidates target treatment of hyperammonemia in urea cycle disorders and hepatic encephalopathy. The company was created in Flagship Labs by VC firm Flagship Pioneering, one of the largest VCs specializing in the biotech and healthcare space.
$20.00 - $22.00/share ***Priced at $15.00/share***
Shares: 4,761,905 shares ~16.2% float ***Upsize to offer 5 million shares***
Kaleido Biosciences is a Massachusetts-based, early clinical-stage microbiome metabolic therapies (MMT) company founded in 2015. The company has conducted several non-IND human clinical studies with its most advanced product candidates in the pipeline under potential IND Filing stage and intend to initiate a Phase 2 clinical trial in first half of 2019. Lead product candidates target treatment of hyperammonemia in urea cycle disorders and hepatic encephalopathy. The company was created in Flagship Labs by VC firm Flagship Pioneering, one of the largest VCs specializing in the biotech and healthcare space.
See more details
JDC (TRADING)
March 5, 2019
1887 JP
490.00 - 510.00 yen/share
Offer Size: 13.46 million shares ~13.7% float
Founded in 1951, JDC is a Japanese construction and civil engineering company.
The final offer price was set at 510 yen/share.
490.00 - 510.00 yen/share
Offer Size: 13.46 million shares ~13.7% float
Founded in 1951, JDC is a Japanese construction and civil engineering company.
The final offer price was set at 510 yen/share.
See more details
Ecopro BM (TRADING)
March 5, 2019
KOSDAQ
247540 KS
37,500 - 42,900 won/share ***Priced at ₩48,000/share***
Offer Shares: 3.6 million shares ~18.1% float (Upsized from 3.00 million shares offering)
Ecopro BM is a 2016 spin-off from the parent company ECOPRO. Ecopro BM is a material/battery company that specializes in developing and the mass-producing of nickel cathode materials in Korea.
37,500 - 42,900 won/share ***Priced at ₩48,000/share***
Offer Shares: 3.6 million shares ~18.1% float (Upsized from 3.00 million shares offering)
Ecopro BM is a 2016 spin-off from the parent company ECOPRO. Ecopro BM is a material/battery company that specializes in developing and the mass-producing of nickel cathode materials in Korea.
See more details
Yincheng International (TRADING)
March 6, 2019
Hong Kong Stock Exchange
1902 HK
HK$2.00 - HK$2.48/share ***Priced at HK$2.38/share***
Shares: 354,260,000 shares ~25% float
Yincheng International is a Chinese property developer in Nanjing and the surrounding Yangtze River Delta Megalopolis. The company has been engaged in property development with a track record in Nanjing since 2002. Sale of residential and commercial properties (~98.7%) and rental income from investment properties owned by the group (1.3%) are the only sources of revenue. Yincheng International outsource construction works of all its property development projects.
HK$2.00 - HK$2.48/share ***Priced at HK$2.38/share***
Shares: 354,260,000 shares ~25% float
Yincheng International is a Chinese property developer in Nanjing and the surrounding Yangtze River Delta Megalopolis. The company has been engaged in property development with a track record in Nanjing since 2002. Sale of residential and commercial properties (~98.7%) and rental income from investment properties owned by the group (1.3%) are the only sources of revenue. Yincheng International outsource construction works of all its property development projects.
See more details
Shockwave Medical (TRADING)
March 7, 2019
NASDAQ GM
SWAV US
US$14.00 - US$16.00/share ***Priced at $17/share***
Offer Shares: 5,000,000 shares ~19.52% float ***Upsized to 5,700,000 shares***
Shockwave is a medical device company for the treatment of atherosclerosis. Incorporated in 2009, the company has two commercialized products, M5 catheter in both United States and Europe since 2018 for treating peripheral artery disease, and C2 catheter in Europe for treating coronary artery disease. The company holds its R&D facility in Santa Clara, CA and a manufacture sit in Fremont. The company is trading at P/E x30+ times. Certain existing shareholders have options to purchase up to $10.5 million of the offering (~13%)
US$14.00 - US$16.00/share ***Priced at $17/share***
Offer Shares: 5,000,000 shares ~19.52% float ***Upsized to 5,700,000 shares***
Shockwave is a medical device company for the treatment of atherosclerosis. Incorporated in 2009, the company has two commercialized products, M5 catheter in both United States and Europe since 2018 for treating peripheral artery disease, and C2 catheter in Europe for treating coronary artery disease. The company holds its R&D facility in Santa Clara, CA and a manufacture sit in Fremont. The company is trading at P/E x30+ times. Certain existing shareholders have options to purchase up to $10.5 million of the offering (~13%)
See more details
Lightspeed POS (TRADING)
March 8, 2019
Toronto Stock Exchange
LSPD CN
CA$13.00 - CA$15.00/share ***Priced at CA$16.00/share***
Offer Shares: 15,000,000 shares, ~22.86% float
Headquartered in Montreal, Canada, Lightspeed POS is a software company established in 2012. Lightspeed provides an e-commerce platform for small and medium sized businesses with a focus on retailer and restaurateur. The company also provides point to sale (POS) system and payment solutions for small businesses to manage daily operations.
CA$13.00 - CA$15.00/share ***Priced at CA$16.00/share***
Offer Shares: 15,000,000 shares, ~22.86% float
Headquartered in Montreal, Canada, Lightspeed POS is a software company established in 2012. Lightspeed provides an e-commerce platform for small and medium sized businesses with a focus on retailer and restaurateur. The company also provides point to sale (POS) system and payment solutions for small businesses to manage daily operations.
See more details
Futu (TRADING)
March 8, 2019
NASDAQ GM
FHL US (ADR)
US$10.00 - 12.00/share ***Priced at $12.00/share***
Offer Shares: 7,500,000 ADSs (Each ADS represents eight Class A ordinary shares) ~17.24% float of Class A shares; or ~6.72% float of all class shares ***Downsized from 10.9 million ADSs***
Futu is a online-based brokerage services company in Hong Kong and China. Founded in 2007 as a internet technology and software development services, the company launched the online brokerage business in 2012 and has a significant market share in the online retail securities markets in both Hong Kong and China since 2015. Futu provides a technology-empowered brokerage platform. Futu generates the majority revenue from brokerage commission and handling charge (~50.3%) and interest income (~44.4%). The company has post positive earnings in 2018. Backed by Tencent, Matrix & Sequoia Capital, Futu is valued at close to $1.3 billion. While the valuation of the firm was at $2.5 billion end of 2018. Futu has entered a concurrent private placement with General Atlantic Singapore to purchase US$70 million in Class A shares at offer price (if within range).
US$10.00 - 12.00/share ***Priced at $12.00/share***
Offer Shares: 7,500,000 ADSs (Each ADS represents eight Class A ordinary shares) ~17.24% float of Class A shares; or ~6.72% float of all class shares ***Downsized from 10.9 million ADSs***
Futu is a online-based brokerage services company in Hong Kong and China. Founded in 2007 as a internet technology and software development services, the company launched the online brokerage business in 2012 and has a significant market share in the online retail securities markets in both Hong Kong and China since 2015. Futu provides a technology-empowered brokerage platform. Futu generates the majority revenue from brokerage commission and handling charge (~50.3%) and interest income (~44.4%). The company has post positive earnings in 2018. Backed by Tencent, Matrix & Sequoia Capital, Futu is valued at close to $1.3 billion. While the valuation of the firm was at $2.5 billion end of 2018. Futu has entered a concurrent private placement with General Atlantic Singapore to purchase US$70 million in Class A shares at offer price (if within range).
See more details
Zhejiang New Century Hotel Management (TRADING)
March 11, 2019
Hong Kong Stock Exchange
1158 HK
HK$13.37 - HK$20.05/share ***Priced at HK$16.50/share***
Offer Size: 70,000,000 H shares
Zhejiang New Century Hotel Management is a hotel group in China. The company operates and manages mid-scale to upscale resort hotels, full service hotels and select service hotels. The hotel group was established in 1988 in Hangzhou, Zhejiang. The group generate revenue through hotel operation (~90%) and hotel management (~10%). New Century has leased ~22.3% of hotel rooms in operation and owns ~1.2% of the hotel room in operation. The group has ~65.6% of hotel rooms in operation under full service management agreement and ~10.9% of the hotel rooms in operation pursuant to the franchise agreement. Ctrip Hong Kong (CTRP US) and GreenTree Hospitality Group (GHG US) has agreed to purchase a total of US$62 million of the offering (~50%).
See more details
DWF Group (TRADING)
March 11, 2019
London Stock Exchange
DWF LN
GBp 122.00/share
Offer Shares: 78.05 million
GBp 122.00/share
Offer Shares: 78.05 million
See more details
Sankei Real Estate (TRADING)
March 12, 2019
Tokyo Stock Exchange
2972 JP (REIT)
JP 98,000 - 100,000 yen/share ***Priced at 100,000 yen/share***
Shares Offered: 227,200 shares
Established in 2018, Sankei Real Estate Inc is under management by Sankei Building Asset Management Co., Ltd., a wholly owned subsidiary of The Sankei Building Co., Ltd. Sankei Building is a Japanese real estate company active in real-estate construction, leasing, brokerage, management and other associated businesses since 1951.
JP 98,000 - 100,000 yen/share ***Priced at 100,000 yen/share***
Shares Offered: 227,200 shares
Established in 2018, Sankei Real Estate Inc is under management by Sankei Building Asset Management Co., Ltd., a wholly owned subsidiary of The Sankei Building Co., Ltd. Sankei Building is a Japanese real estate company active in real-estate construction, leasing, brokerage, management and other associated businesses since 1951.
See more details
WingArc1st (WITHDRAWN)
March 13, 2019
Tokyo Stock Exchange
4432 JP
JP 1,690 - 1,970 yen/share
Founded in 1993 and headquartered in Tokyo, WingArc1st is a Japan-based software company that provides data solution for companies. WingArc offers enterprise management software platforms.
WingArc1st is set to raise up to 41.28 billion yen (US$379.35 m)
JP 1,690 - 1,970 yen/share
Founded in 1993 and headquartered in Tokyo, WingArc1st is a Japan-based software company that provides data solution for companies. WingArc offers enterprise management software platforms.
WingArc1st is set to raise up to 41.28 billion yen (US$379.35 m)
See more details
Dreamtech (TRADING)
March 14, 2019
Korea Exchange
192650 KS
Price Range: KRW11,000 - KRW13,000/share ***Priced ₩13,000/share***
Founded in 1998 as a Samsunng Electronics partner company in Korea, Dreamtech develops and produces automotive LED and home appliance LCD display modules as well as sensor, touch, finger scan modules for mobile phones.
Price Range: KRW11,000 - KRW13,000/share ***Priced ₩13,000/share***
Founded in 1998 as a Samsunng Electronics partner company in Korea, Dreamtech develops and produces automotive LED and home appliance LCD display modules as well as sensor, touch, finger scan modules for mobile phones.
See more details
Binjiang Service Group (TRADING)
March 15, 2019
Hong Kong Stock Exchange
3316 HK
HK$5.40 - 7.00/share ***Priced at HK6.96/share***
Offer Shares: 66.70 million
Established in 1995, Binjiang Service Group is a property management service provider in China (with a substantial market share in high-end residential properties in Hangzhou). The revenue of Binjiang can be divided into three main segments including property management services (64.9%), value-added services to non-property owners (27.5%), and value-added services to property owners (7.6%). Three cornerstone investors have agreed to subscribe a total of over 40% of the total offer shares.
HK$5.40 - 7.00/share ***Priced at HK6.96/share***
Offer Shares: 66.70 million
Established in 1995, Binjiang Service Group is a property management service provider in China (with a substantial market share in high-end residential properties in Hangzhou). The revenue of Binjiang can be divided into three main segments including property management services (64.9%), value-added services to non-property owners (27.5%), and value-added services to property owners (7.6%). Three cornerstone investors have agreed to subscribe a total of over 40% of the total offer shares.
See more details
China Risun Group (TRADING)
March 15, 2019
Hong Kong Stock Exchange
1907 HK
HK$2.76 - HK$3.18/share ***Priced at HK$2.80/share***
Offer Shares: 600 million shares ~22.1% float
China Risun Group is an integrated coke, coking chemical and refined chemical producer and supplier in China. The group was established in 1995 with all production bases in Hebei province. The revenue breakdown to coke and coking chemical (45.5%), refined chemicals (41.0%) and trading (13.5%). The major customers are iron and steel industry participators and chemical products manufacturers. The five largest customers accounts for ~18.1% of Risun's total revenue. 8 cornerstone investors have agreed to purchase ~40% of the offering
HK$2.76 - HK$3.18/share ***Priced at HK$2.80/share***
Offer Shares: 600 million shares ~22.1% float
China Risun Group is an integrated coke, coking chemical and refined chemical producer and supplier in China. The group was established in 1995 with all production bases in Hebei province. The revenue breakdown to coke and coking chemical (45.5%), refined chemicals (41.0%) and trading (13.5%). The major customers are iron and steel industry participators and chemical products manufacturers. The five largest customers accounts for ~18.1% of Risun's total revenue. 8 cornerstone investors have agreed to purchase ~40% of the offering
See more details
International Alliance Financial Leasing (TRADING)
March 15, 2019
Hong Kong Stock Exchange
1563 HK
HK$0.84 - 1.67/share ***Priced at HK$0.85/share***
Offer Shares: 495.00 million ~33% float
Established in 2014 as Nanshan Leasing, a wholly-owned subsidiary of Nanshan Group, International Alliance Financial Leasing (AI Leasing) is a finance leasing and advisory services provider in China. Headquartered in Beijing, AI Leasing targeted customers in the healthcare, aviation and public infrastructure industries. It is one of the largest independent non-state owned aircraft finance leasing company in China. AI Leasing profit from both sale-leaseback (~86% of revenue) and direct finance leasing (~14%). Union Capital will control approximately 51.23% of the company upon completion of the offering.
HK$0.84 - 1.67/share ***Priced at HK$0.85/share***
Offer Shares: 495.00 million ~33% float
Established in 2014 as Nanshan Leasing, a wholly-owned subsidiary of Nanshan Group, International Alliance Financial Leasing (AI Leasing) is a finance leasing and advisory services provider in China. Headquartered in Beijing, AI Leasing targeted customers in the healthcare, aviation and public infrastructure industries. It is one of the largest independent non-state owned aircraft finance leasing company in China. AI Leasing profit from both sale-leaseback (~86% of revenue) and direct finance leasing (~14%). Union Capital will control approximately 51.23% of the company upon completion of the offering.
See more details
Aoyuan Healthy Life Group (TRADING)
March 18, 2019
Hong Kong Stock Exchange
3662 HK
HK$3.48 - 4.30/share
Offer Shares: 175.00 million ~25% float
Aoyuan Healthy Life is a property management service and commercial operational service provider in China since 2011. This listing will constitute a spin-off from China Aoyuan.
The Group provides conventional property management services for both residential and non-residential properties from sales assistance to community value-added services. Aoyuan also provides commercial operational services from business tenant sourcing services to management services for shopping malls. The company generates approximately 2/3 of revenue from conventional property management (72.8%). While Aoyuan work with third-party property developers, 94.7 % of its revenue were from managing properties developed by its parent company. Immediately following the completion of this offering, China Aoyuan will still hold ~56.6% of the total issued shares, while Dawn Agile, the pre-IPO investor of Aoyuan Healthy Life, will hold ~18.4%. Cornerstone investor has agreed to subscribe >5% of this offer.
HK$3.48 - 4.30/share
Offer Shares: 175.00 million ~25% float
Aoyuan Healthy Life is a property management service and commercial operational service provider in China since 2011. This listing will constitute a spin-off from China Aoyuan.
The Group provides conventional property management services for both residential and non-residential properties from sales assistance to community value-added services. Aoyuan also provides commercial operational services from business tenant sourcing services to management services for shopping malls. The company generates approximately 2/3 of revenue from conventional property management (72.8%). While Aoyuan work with third-party property developers, 94.7 % of its revenue were from managing properties developed by its parent company. Immediately following the completion of this offering, China Aoyuan will still hold ~56.6% of the total issued shares, while Dawn Agile, the pre-IPO investor of Aoyuan Healthy Life, will hold ~18.4%. Cornerstone investor has agreed to subscribe >5% of this offer.
See more details
Copro-Holdings (TRADING)
March 19, 2019
Tokyo Stock Exchange
7059 JP
JPY 2050.00 - 2090.00/share
Offer Shares: 1.40 million, ~28% float
Established in 2006 as Copro-Engineered, Copro is a recruitment company that operates in the temporary staffing business with a focus on construction engineers in Japan.
JPY 2050.00 - 2090.00/share
Offer Shares: 1.40 million, ~28% float
Established in 2006 as Copro-Engineered, Copro is a recruitment company that operates in the temporary staffing business with a focus on construction engineers in Japan.
See more details
Minkabu The Infonoid (TRADING)
March 19, 2019
Tokyo Stock Exchange
4436 JP
JPY 950.00 - 1,050.00/share ***Priced at 1,050 yen/share***
Offer Size: 2,740,200 shares, ~21.86% float
Founded in 2006 and commenced operation in 2007, Minkabu the Infonoid is a Tokyo, Japan-based fiinancial news media company. Minkabu provides financial information using crowd analysis and automatic analysis. The company supports multiple media companies to provide stock information and fx information. Minkabu also offers system development service.
JPY 950.00 - 1,050.00/share ***Priced at 1,050 yen/share***
Offer Size: 2,740,200 shares, ~21.86% float
Founded in 2006 and commenced operation in 2007, Minkabu the Infonoid is a Tokyo, Japan-based fiinancial news media company. Minkabu provides financial information using crowd analysis and automatic analysis. The company supports multiple media companies to provide stock information and fx information. Minkabu also offers system development service.
See more details
Up Fintech (TRADING)
March 20, 2019
NASDAQ GS
TIGR US
Price Range: $5.00 - $7.00/ADS ***Priced at $8.00/share***
Shares Offered: 13,000,000 ADS (representing 195,000,000 Class A shares) ~11.8% float of Class A shares; or ~9.8% float (of total ordinary shares Class A & B)
Up Fintech (Tiger Brokers) is a Chinese online brokerage platform developer and operator. Headquartered in Beijing, the company was founded in 2014. The trading platform was launched in August 2015. Tiger is claimed to be the largest online broker for Chinese investors in terms of U.S. securities trading with a market share of approximately 58.4%. Yet, it has not been profitable since inception. The company provides brokerage services, corporate services and asset management. Tiger generates majority revenue from commission fees (77.6%) generated from brokerage services and financing service fees and interest income (19.4%) from margin loans and short selling services. Interactive Brokers (through IB Global Investment LLC) and Xiaomi (through People Better Limited) will hold ~7.6% and 12.6% of the company respectively. The company relies on Interactive Brokers to execute, settle and clear trades and to perform margin financing services. It is an "introducing broker" to Interactive Brokers but with a valuation close to $1.0 billion.
Price Range: $5.00 - $7.00/ADS ***Priced at $8.00/share***
Shares Offered: 13,000,000 ADS (representing 195,000,000 Class A shares) ~11.8% float of Class A shares; or ~9.8% float (of total ordinary shares Class A & B)
Up Fintech (Tiger Brokers) is a Chinese online brokerage platform developer and operator. Headquartered in Beijing, the company was founded in 2014. The trading platform was launched in August 2015. Tiger is claimed to be the largest online broker for Chinese investors in terms of U.S. securities trading with a market share of approximately 58.4%. Yet, it has not been profitable since inception. The company provides brokerage services, corporate services and asset management. Tiger generates majority revenue from commission fees (77.6%) generated from brokerage services and financing service fees and interest income (19.4%) from margin loans and short selling services. Interactive Brokers (through IB Global Investment LLC) and Xiaomi (through People Better Limited) will hold ~7.6% and 12.6% of the company respectively. The company relies on Interactive Brokers to execute, settle and clear trades and to perform margin financing services. It is an "introducing broker" to Interactive Brokers but with a valuation close to $1.0 billion.
See more details
Diaceutics (TRADING)
March 21, 2019
London Stock Exchange
DXRX LN
Priced 76.00 pence/share
Shares Offered: 22,368,427
Founded in 2005, Diaceutics is a commercialized diagnostic data analytics and implementation services provider. The company provides services to pharmaceutical companies to support precision medicine therapies.
Priced 76.00 pence/share
Shares Offered: 22,368,427
Founded in 2005, Diaceutics is a commercialized diagnostic data analytics and implementation services provider. The company provides services to pharmaceutical companies to support precision medicine therapies.
See more details
Levi Strauss & Co (TRADING)
March 21, 2019
NYSE
LEVI US
Price Range: $14.00 - $16.00/share ***Priced at $17.00/share***
Shares Offered: 36,666,667 shares Class A common stock (9,466,557 shares NEW shares & 27,200,110 shares offered by selling stockholders) ~9.5% float (of total Class A and B common stock outstanding)
Founded in San Francisco, CA in 1853, Levi Strauss is a jean apparel company that invented blue jeans. Levi's was once traded on NYSE in 1971 but returned to being a privately-held company in 1985. The iconic-jeans company also established global market share position in non-jeans bottoms and tops as well as footwear and accessories in U.S., Europe (29% of net revenues) and Asia (16% of net revenues). Wholesale channel, franchise stores sales, and DTC channel (company-operated mainline and outlet stores, shop-in-shop, eCommerce sites) accounts for 57%, 7% and 35% of net revenues in 2018 respectively.
Levi's is valued at close to $6.2 billion if priced on high-end. The denim company has a P/S ratio of 1.1x and a dividend yield of ~1.78% at current valuation. The Haas family will still hold ~82.1% of total voting power following the offering.
Price Range: $14.00 - $16.00/share ***Priced at $17.00/share***
Shares Offered: 36,666,667 shares Class A common stock (9,466,557 shares NEW shares & 27,200,110 shares offered by selling stockholders) ~9.5% float (of total Class A and B common stock outstanding)
Founded in San Francisco, CA in 1853, Levi Strauss is a jean apparel company that invented blue jeans. Levi's was once traded on NYSE in 1971 but returned to being a privately-held company in 1985. The iconic-jeans company also established global market share position in non-jeans bottoms and tops as well as footwear and accessories in U.S., Europe (29% of net revenues) and Asia (16% of net revenues). Wholesale channel, franchise stores sales, and DTC channel (company-operated mainline and outlet stores, shop-in-shop, eCommerce sites) accounts for 57%, 7% and 35% of net revenues in 2018 respectively.
Levi's is valued at close to $6.2 billion if priced on high-end. The denim company has a P/S ratio of 1.1x and a dividend yield of ~1.78% at current valuation. The Haas family will still hold ~82.1% of total voting power following the offering.
See more details
Alight (POSTPONE)
March 22, 2019
NASDAQ GS
ALIT US
Price Range: $22.00 - $25.00/share
Shares Offered: 32,000,000 shares, ~24% float (or 16% if Pre-IPO Unitholders exchange all LLC Units)
Alight (previously Aon's benefits admin and HR BPO platform) is a Human Capital Management (HCM) company focus on providing solutions for clients to manage health, wealth and HR needs. Headquartered in Lincolnshire, IL, Alight has 25+ years experiences in the HR space in hosted business and cloud-based solutions. Hosted service is scheduled to expire by 2023 and the company will solely focus on cloud-based HR solutions. Alight has entered into strategic partnerships with Alegeus and Personal Capital for its health and wealth business segment, and Workday for its cloud HCM platform services. Blackstone acquired Alight from Aon in 2017 for $4.3 billion. Blackstone will hold ~30% of the outstanding Class A common stock and ~40% of voting power. Other significant shareholders includes Abu Dhabi Investment Authority (ADIA) and GIC. Valued at ~$5.1 billion, the company has a P/S ratio of ~2.15x if priced at $25.00/share.
Price Range: $22.00 - $25.00/share
Shares Offered: 32,000,000 shares, ~24% float (or 16% if Pre-IPO Unitholders exchange all LLC Units)
Alight (previously Aon's benefits admin and HR BPO platform) is a Human Capital Management (HCM) company focus on providing solutions for clients to manage health, wealth and HR needs. Headquartered in Lincolnshire, IL, Alight has 25+ years experiences in the HR space in hosted business and cloud-based solutions. Hosted service is scheduled to expire by 2023 and the company will solely focus on cloud-based HR solutions. Alight has entered into strategic partnerships with Alegeus and Personal Capital for its health and wealth business segment, and Workday for its cloud HCM platform services. Blackstone acquired Alight from Aon in 2017 for $4.3 billion. Blackstone will hold ~30% of the outstanding Class A common stock and ~40% of voting power. Other significant shareholders includes Abu Dhabi Investment Authority (ADIA) and GIC. Valued at ~$5.1 billion, the company has a P/S ratio of ~2.15x if priced at $25.00/share.
See more details
IntelliCentrics Global (TRADING)
March 27, 2019
Hong Kong Stock Exchange
6819 HK
Price Range: HK$5.32 - HK7.19/share ***Priced at HK$5.35/share***
Shares Offered: 80,900,000 shares ~18% float
Headquartered in Dallas, Texas, IntelliCentrics Global operates a credentialing platform for compliance and security purposes in the healthcare industry. The company as formed in 2007 as USA deView acquired certain assets of RepTrax to provide solutions for healthcare providers with a paying subscription platform. The platform collects, processes and verifies data and information in accordance of locations where healthcare services are provided (LoCs). IntelliCentrics offers both vendor credentialing solution, medical credentialing solution and add-on services (include onling training etc.). 94% of revenue was generated from subscription fees for the vendor credentialing solution. IntelliCentrics operates in the United States (98.77%), Canada (0.05%) and United Kingdom (1.18%) and is entering into the Chinese market.
Price Range: HK$5.32 - HK7.19/share ***Priced at HK$5.35/share***
Shares Offered: 80,900,000 shares ~18% float
Headquartered in Dallas, Texas, IntelliCentrics Global operates a credentialing platform for compliance and security purposes in the healthcare industry. The company as formed in 2007 as USA deView acquired certain assets of RepTrax to provide solutions for healthcare providers with a paying subscription platform. The platform collects, processes and verifies data and information in accordance of locations where healthcare services are provided (LoCs). IntelliCentrics offers both vendor credentialing solution, medical credentialing solution and add-on services (include onling training etc.). 94% of revenue was generated from subscription fees for the vendor credentialing solution. IntelliCentrics operates in the United States (98.77%), Canada (0.05%) and United Kingdom (1.18%) and is entering into the Chinese market.
See more details
Genfit (TRADING)
March 27, 2019
NASDAQ GM
GNFT US (ADR)
GNFT FP (12/11/2006 IPO priced at €9.00/share, listed on Euronext Paris)
Offering price will be determined by price of its ordinary shares on Euronext Paris. On March 13, 2019, the last reported sale price of our ordinary shares on Euronext Paris was €23.42 per ordinary share, equivalent to a price of $26.33 per ADS, assuming an exchange rate of €0.8894 per U.S. dollar, the exchange rate on March 8, 2019.*
***Priced at $20.32/share***
Shares Offered: 5,000,000 shares ***Upsized to offer 6.65 million ADS***
Genfit is a late-stage clinical biopharmaceutical company targeting metabolic and liver related diseases. The lead drug candidate is under Phase 3 clinical trial and Phase 2 clinical trial for potential treatment for nonalcoholic steatohepatitis and primary biliary cholangitis respectively. The company was incorporated in 1999 in France. The company generates some revenue principally from tax credits, sublease of corporate headquarteres, funds from co-research alliances from the past.
GNFT FP (12/11/2006 IPO priced at €9.00/share, listed on Euronext Paris)
Offering price will be determined by price of its ordinary shares on Euronext Paris. On March 13, 2019, the last reported sale price of our ordinary shares on Euronext Paris was €23.42 per ordinary share, equivalent to a price of $26.33 per ADS, assuming an exchange rate of €0.8894 per U.S. dollar, the exchange rate on March 8, 2019.*
***Priced at $20.32/share***
Shares Offered: 5,000,000 shares ***Upsized to offer 6.65 million ADS***
Genfit is a late-stage clinical biopharmaceutical company targeting metabolic and liver related diseases. The lead drug candidate is under Phase 3 clinical trial and Phase 2 clinical trial for potential treatment for nonalcoholic steatohepatitis and primary biliary cholangitis respectively. The company was incorporated in 1999 in France. The company generates some revenue principally from tax credits, sublease of corporate headquarteres, funds from co-research alliances from the past.
See more details
Genomictree (TRADING)
March 27, 2019
KOSDAQ
228760 KS Listed on Konex since 7/19/2016
The shares were first listed on Konex Exchange on 7/19/2016
Price Range: ₩17,000 - ₩25,000/share ***Priced at 27,000 won/share***
Shares Offered: 4.00 million shares
Founded in 2000, Genomictree is a molecular diagnostic company that provides diagnostic technology and product for healthcare market. The company had a commercialized DNA methylation biomarker-based non-invasive cancer molecular diagnostic product for the early detection of cancer. The detection product for colorectal cancer was approved by Korea FDA in 2014.
The shares were first listed on Konex Exchange on 7/19/2016
Price Range: ₩17,000 - ₩25,000/share ***Priced at 27,000 won/share***
Shares Offered: 4.00 million shares
Founded in 2000, Genomictree is a molecular diagnostic company that provides diagnostic technology and product for healthcare market. The company had a commercialized DNA methylation biomarker-based non-invasive cancer molecular diagnostic product for the early detection of cancer. The detection product for colorectal cancer was approved by Korea FDA in 2014.
See more details
Koolearn Technology (TRADING)
March 28, 2019
Hong Kong Stock Exchange
1797 HK
Price Range HK$9.30 - HK$11.10/share ***Priced at HK$10.2/share***
Shares Offered: 164,513,000 shares ~18.00% float
Koolearn Technology is a spin off of New Oriental (EDU US) with previously listing history on NEEQ (8398966) in China. The company provides online extracurricular education service in China leveraged on New Oriental's brand recognition. Koolearn provides college education (college test preparation, overseas test preparation, English learning etc.,) K-12 education, and little pre-school education for both individual students and institutional customers such as universities, public libraries and online video streaming service providers.
Price Range HK$9.30 - HK$11.10/share ***Priced at HK$10.2/share***
Shares Offered: 164,513,000 shares ~18.00% float
Koolearn Technology is a spin off of New Oriental (EDU US) with previously listing history on NEEQ (8398966) in China. The company provides online extracurricular education service in China leveraged on New Oriental's brand recognition. Koolearn provides college education (college test preparation, overseas test preparation, English learning etc.,) K-12 education, and little pre-school education for both individual students and institutional customers such as universities, public libraries and online video streaming service providers.
See more details
Hyundai Autoever (TRADING)
March 28, 2019
Korea Stock Exchange
307950 KS
Price Range: ₩40,000 - ₩44,000/share ***Priced at 48,000 won/share***
Shares Offered: 3.51 million shares
Founded in 2000 and headquartered in Seoul, Hyundai AutoEver is a Korean ICT service provider. The company is owned by Hyundai Motor Group and its affiliates including Kia Motors and Hyundai Mobis. Hyundai AutoEver specializes in software development and system integration and other IT-related services for automobile sales.
Price Range: ₩40,000 - ₩44,000/share ***Priced at 48,000 won/share***
Shares Offered: 3.51 million shares
Founded in 2000 and headquartered in Seoul, Hyundai AutoEver is a Korean ICT service provider. The company is owned by Hyundai Motor Group and its affiliates including Kia Motors and Hyundai Mobis. Hyundai AutoEver specializes in software development and system integration and other IT-related services for automobile sales.
See more details
Precision BioSciences (TRADING)
March 28, 2019
NASDAQ GS
DTIL US
Price Range: US$15.00 - US$17.00/share ***Priced at $16.00/share***
Shares Offered: 7,900,000 shares, ~16.1% float
Founded in 2006 and headquartered in Durham, North Carolina, Precision BioSciences is an early-stage biotech company focus on genome editing. The company recently received the IND from FDA for its first candidate and is screening patients for Phase 1/2a clinical trial for non-hodgkin lymphoma. Precision has a product pipeline in Allogeneic CAR T immunotherapy, in vivo gene correction and food (gene edited crop), while the majority product candidates were still under discovery/preclinical stage. The company entered into several license agreements/collaborations with major pharmaceutical, biotech, and agricultural companies including Shire, Servier, Gilead, and Cargill. Precision also has a close tied to Duke University.
Price Range: US$15.00 - US$17.00/share ***Priced at $16.00/share***
Shares Offered: 7,900,000 shares, ~16.1% float
Founded in 2006 and headquartered in Durham, North Carolina, Precision BioSciences is an early-stage biotech company focus on genome editing. The company recently received the IND from FDA for its first candidate and is screening patients for Phase 1/2a clinical trial for non-hodgkin lymphoma. Precision has a product pipeline in Allogeneic CAR T immunotherapy, in vivo gene correction and food (gene edited crop), while the majority product candidates were still under discovery/preclinical stage. The company entered into several license agreements/collaborations with major pharmaceutical, biotech, and agricultural companies including Shire, Servier, Gilead, and Cargill. Precision also has a close tied to Duke University.
See more details
CanSino Biologics (TRADING)
March 28, 2019
Hong Kong Stock Exchange
6185 HK
Price Range: HK$21.00 - HK$22.00/share ***Priced at HK$22.00/share***
Shares Offered: 57,248,600 shares ~28.24% float
Established in 2009, CanSino is a vaccine company in Tianjin, China. CanSino develops, manufactures vaccines. The company is developing 15 vaccine candidates with 3 near-commercial ones for meningococcal diseases and Ebola virus disease. Cornerstone investors have agreed to subscribe >25% of the total number of offer shares.
Price Range: HK$21.00 - HK$22.00/share ***Priced at HK$22.00/share***
Shares Offered: 57,248,600 shares ~28.24% float
Established in 2009, CanSino is a vaccine company in Tianjin, China. CanSino develops, manufactures vaccines. The company is developing 15 vaccine candidates with 3 near-commercial ones for meningococcal diseases and Ebola virus disease. Cornerstone investors have agreed to subscribe >25% of the total number of offer shares.
See more details
Puyi (TRADING)
March 29, 2019
NASDAQ GM
PUYI US (ADS)
Priced at $6.00/share
Shares Offered: 6,666,668 ADSs ***Downsized to 4,292,276 ADSs***
Priced at $6.00/share
Shares Offered: 6,666,668 ADSs ***Downsized to 4,292,276 ADSs***
See more details
Lyft (TRADING)
March 29, 2019
NASDAQ GS
LYFT US
Price Range: US$62.00 - US$68.00/share
Increased Price Range: US$70.00 - US$72.00/share ***Priced at $72.00/share***
Shares Offered: 30,770,000 shares ~10.8% float of Class A and B outstanding
Lyft is a on-demand ridesharing company launched in 2012 with sole presence in United States and Canada. Lyft offers variety of transportation options from conventional ridesharing, bikes and scooters to public transit and autonomous vehicles services with Aptiv. Lyft is seeking a $20 billion valuation at high-end and a ~8.96x P/S ratio.
Price Range: US$62.00 - US$68.00/share
Increased Price Range: US$70.00 - US$72.00/share ***Priced at $72.00/share***
Shares Offered: 30,770,000 shares ~10.8% float of Class A and B outstanding
Lyft is a on-demand ridesharing company launched in 2012 with sole presence in United States and Canada. Lyft offers variety of transportation options from conventional ridesharing, bikes and scooters to public transit and autonomous vehicles services with Aptiv. Lyft is seeking a $20 billion valuation at high-end and a ~8.96x P/S ratio.
See more details
Amo Greentech (TRADING)
March 29, 2019
KOSDAQ
125210 KS
Price Range: KRW8,800 - 9,900/share ***Priced at 9,900 won/share***
Price Range: KRW8,800 - 9,900/share ***Priced at 9,900 won/share***
See more details
Sun Car Insurance Agency (WITHDRAWN)
March 29, 2019
Hong Kong Stock Exchange
1879 HK
Price Range: HK$23.00 - HK$30.80/share
Shares Offered: 42,626,600 shares, ~25% float
Founded in 2007 under the name Shanghai Sheng Shi Da Lian Insurance, Sun Car is an automobile insurance agency in China that was listed on the NEEQ since 2014. The company offers internet and mobile app-based service platform to provide both car insurance products underwritten by major insurance companies and B2B automobile after-sales service. Sun Car generates revenue by receiving commissions from insurance company (~75% of revenue) and the rest from services fees by providing automobile butler services, which are primarily purchased by major banks and insurance companies for their customer reward programs. Cornerstone investors have agreed to purchase US$30 million of shares (up to 24% of total number of offer shares).
Price Range: HK$23.00 - HK$30.80/share
Shares Offered: 42,626,600 shares, ~25% float
Founded in 2007 under the name Shanghai Sheng Shi Da Lian Insurance, Sun Car is an automobile insurance agency in China that was listed on the NEEQ since 2014. The company offers internet and mobile app-based service platform to provide both car insurance products underwritten by major insurance companies and B2B automobile after-sales service. Sun Car generates revenue by receiving commissions from insurance company (~75% of revenue) and the rest from services fees by providing automobile butler services, which are primarily purchased by major banks and insurance companies for their customer reward programs. Cornerstone investors have agreed to purchase US$30 million of shares (up to 24% of total number of offer shares).
See more details
Shanghai Dongzheng Automotive Finance (TRADING)
April 3, 2019
Hong Kong Stock Exchange
2718 HK
Price Range: HK$4.20 - HK$6.30/share ***Priced at HK$3.06/share, deal postponed for a week from original scheduled***
Shares Offered: 533,336,000 shares ~25.00% float
Established in 2015, Shanghai Dongzheng Automotive Finance is a spin-off of ZhengTong, a Chinese luxury-brand car dealer group. Shanghai Dongzheng Automotive Finance provides tailored auto finance products and services for the purchase of luxury-brand cars. Shanghai Dongzheng generates revenue from interest, fee and commission from both self-operated retail loan, retail loan facilitation and dealer loan business.
Price Range: HK$4.20 - HK$6.30/share ***Priced at HK$3.06/share, deal postponed for a week from original scheduled***
Shares Offered: 533,336,000 shares ~25.00% float
Established in 2015, Shanghai Dongzheng Automotive Finance is a spin-off of ZhengTong, a Chinese luxury-brand car dealer group. Shanghai Dongzheng Automotive Finance provides tailored auto finance products and services for the purchase of luxury-brand cars. Shanghai Dongzheng generates revenue from interest, fee and commission from both self-operated retail loan, retail loan facilitation and dealer loan business.
See more details
Ruhnn (TRADING)
April 3, 2019
NASDAQ GS
RUHN US (ADS)
Price Range: $11.50 - $13.50/share ***Priced at $12.50/share***
Shares Offered: 10,000,000 ADS ~12.1% float
Founded in 2016 as Hanyi E-Commerce, Ruhnn is a Chinese internet influencer (key opinion leader, or KOL) incubator and facilitator. The company commercializes on the signed internet influencers and generates revenues through influencers 'ecosystem'. Ruhnn provides professional training and support to KOLs to grow fan bases, manages KOLs' social media accounts to promote and endorse products tailored to specific fan bases, owns and operates online stores on third-party e-commerce platforms and generates revenues through online sales (~88%) and related services (~12%). One of the company's top-tier influencer is accounted for, on average, 50% of the GMV. The company is valued at little over $1.0 billion with a P/S at 8.3x. Taobao (owned by Alibaba) owns 7.5% of total shares outstanding after the offering.
Price Range: $11.50 - $13.50/share ***Priced at $12.50/share***
Shares Offered: 10,000,000 ADS ~12.1% float
Founded in 2016 as Hanyi E-Commerce, Ruhnn is a Chinese internet influencer (key opinion leader, or KOL) incubator and facilitator. The company commercializes on the signed internet influencers and generates revenues through influencers 'ecosystem'. Ruhnn provides professional training and support to KOLs to grow fan bases, manages KOLs' social media accounts to promote and endorse products tailored to specific fan bases, owns and operates online stores on third-party e-commerce platforms and generates revenues through online sales (~88%) and related services (~12%). One of the company's top-tier influencer is accounted for, on average, 50% of the GMV. The company is valued at little over $1.0 billion with a P/S at 8.3x. Taobao (owned by Alibaba) owns 7.5% of total shares outstanding after the offering.
See more details
Medacta Group (TRADING)
April 4, 2019
SIX Swiss Exchange
MOVE SW
Price Range: 88.00 - 104.00 Swiss Franc/share ***Priced at 96 franc/share***
Shares Offered: 6,555,000 exiting shares (offered by members of Siccardi family) ~28.50% float
Medacta is a family-owned, Switzerland-based medical device company. The company develops and manufactures hip, knees and other orthopedic implants as well as neurosurgical and miscellaneous medical devices. The medical technology company is valued at 2.08 billion Swiss Franc with a 6.9x P/S ratio.
Price Range: 88.00 - 104.00 Swiss Franc/share ***Priced at 96 franc/share***
Shares Offered: 6,555,000 exiting shares (offered by members of Siccardi family) ~28.50% float
Medacta is a family-owned, Switzerland-based medical device company. The company develops and manufactures hip, knees and other orthopedic implants as well as neurosurgical and miscellaneous medical devices. The medical technology company is valued at 2.08 billion Swiss Franc with a 6.9x P/S ratio.
See more details
NGM Biopharmaceuticals (TRADING)
April 4, 2019
NASDAQ GS
NGM US
Price Range: $14.00 - $16.00/share ***Priced at $16.0/share***
Shares Offered: 6,666,667 shares ~10.26% float
NGM is a South San Francisco-based clinical-stage biopharmaceutical company with seven product candidates primarily focus on liver diseases. The company commenced operations in 2008 and has advanced its top wholly-owned product candidate to Phase 2b for the treatment of non-alcoholic steatohepatitis (NASH). NGM has a 7-year research collaboration license (to 2022) with Merck Sharp & Dohme Corp. Merck has agreed to purchase approximately 19.9% of total outstanding shares of common stock.
Price Range: $14.00 - $16.00/share ***Priced at $16.0/share***
Shares Offered: 6,666,667 shares ~10.26% float
NGM is a South San Francisco-based clinical-stage biopharmaceutical company with seven product candidates primarily focus on liver diseases. The company commenced operations in 2008 and has advanced its top wholly-owned product candidate to Phase 2b for the treatment of non-alcoholic steatohepatitis (NASH). NGM has a 7-year research collaboration license (to 2022) with Merck Sharp & Dohme Corp. Merck has agreed to purchase approximately 19.9% of total outstanding shares of common stock.
See more details
Tradeweb Markets (TRADING)
April 4, 2019
NASDAQ GS
TW US
Price Range: $24.00 - $26.00/share ***Priced at $27/0/share***
Shares Offered: 27,268,767 shares ~12.27% float of all Class A, B, C, D & LLC Interests outstanding (~22% float of all Class A and B shares) ***Upsized to 36,250,000 shares***
Founded in 1996, Tradeweb is an electronic trading marketplaces developer and operator. The company through its operating subsidiaries provide transactions, trading and market data and electronic and voice brokerage services. Tradeweb generates revenues from transactions fees (~54%), subscription fees (and market data fees) (~27%), and commissions (~18%). Refinitiv, the former Thomson Reuters's financial and risk business, now co-owned by Blackstone Group and Thomson Reuters, will remain control (with 63.6% voting power) after this offering. Tradeweb is selling at a 9.1x P/S and will be paying quarterly cash dividends of $0.08/share.
Price Range: $24.00 - $26.00/share ***Priced at $27/0/share***
Shares Offered: 27,268,767 shares ~12.27% float of all Class A, B, C, D & LLC Interests outstanding (~22% float of all Class A and B shares) ***Upsized to 36,250,000 shares***
Founded in 1996, Tradeweb is an electronic trading marketplaces developer and operator. The company through its operating subsidiaries provide transactions, trading and market data and electronic and voice brokerage services. Tradeweb generates revenues from transactions fees (~54%), subscription fees (and market data fees) (~27%), and commissions (~18%). Refinitiv, the former Thomson Reuters's financial and risk business, now co-owned by Blackstone Group and Thomson Reuters, will remain control (with 63.6% voting power) after this offering. Tradeweb is selling at a 9.1x P/S and will be paying quarterly cash dividends of $0.08/share.
See more details
Silk Road Medical (TRADING)
April 4, 2019
NASDAQ GM
SILK US
Price Range: $15.00 - $17.00/share ***Amended Price Range $19.00 - $20.00/share***
***Priced at $20.0/share***
Shares Offered: 4,687,500 shares ~16.33% float ***Upsized to 6,000,000 shares ~19.87% float***
Founded in 2007, Silk Road Medical is a medical device company located in Sunnyvale, CA. The company develops minimally-invasive surgical devices for patients with carotid artery disease who are at risk for stroke. Silk Road commercialized its products in U.S. since April 2016. The company is valued at approximately $600 million at P/S over 17x.
Certain existing investors have indicated an interest to purchase up to $15 million (approximately 20%) from the offering.
Price Range: $15.00 - $17.00/share ***Amended Price Range $19.00 - $20.00/share***
***Priced at $20.0/share***
Shares Offered: 4,687,500 shares ~16.33% float ***Upsized to 6,000,000 shares ~19.87% float***
Founded in 2007, Silk Road Medical is a medical device company located in Sunnyvale, CA. The company develops minimally-invasive surgical devices for patients with carotid artery disease who are at risk for stroke. Silk Road commercialized its products in U.S. since April 2016. The company is valued at approximately $600 million at P/S over 17x.
Certain existing investors have indicated an interest to purchase up to $15 million (approximately 20%) from the offering.
See more details
Network International (TRADING)
April 10, 2019
London Stock Exchange
NETW LN
Price Range: 395.00 - 465.00 pence/share
Shares Offered: 299,950,000 shares (institutional free float of 25%)
Established in 1994 as a subsidiary of Emirates Bank, Network International is a leading digital payment solution provider in the Middle East and Africa region. The company provides a suite of payment products and services. Network generates revenues from two platforms for both merchant and issuer. Middle East market (especially the UAE region) represents 75% of the group's total revenue in 2018.
Network International has an implied market capitalization between 1.98 billion and 2.33 billion pounds ($2.6 billion and $3.1 billion), a P/S ratio of 10.4x. Warburg Pincus and General Atlantic will jointly own 25.73% and Emirates Bank 26.78% after this offering. Mastercard is to put down $300 million cornerstone investment in Network International (~9.99% of stake).
See more details
Adevinta (TRADING)
April 10, 2019
Oslo Stock Exhcange
ADEB NO
Price Range: NOK70.00 - NOK82.00/share
Amended Price Range: NOK75.00 - NOK80.00/share
Shares Offered: 36,893,081 Class B stocks (offered by selling shareholders Schibsted and Blommenholm Industrier)
Adevinta operates in the online classifieds industry since 2018. The company operates online marketplaces in 16 countries (outside the Nordics), connecting buyers seeking goods or services with a large base of sellers. The company develops leading local brands include Leboncoin in France, InfoJobs in Spain, Subito in Italy and Jofogás in Hungary. While Schibsted (SCHA NO) will remain majority ownership of Adevinta, Adevinta will spin off as an independent listed company.
Price Range: NOK70.00 - NOK82.00/share
Amended Price Range: NOK75.00 - NOK80.00/share
Shares Offered: 36,893,081 Class B stocks (offered by selling shareholders Schibsted and Blommenholm Industrier)
Adevinta operates in the online classifieds industry since 2018. The company operates online marketplaces in 16 countries (outside the Nordics), connecting buyers seeking goods or services with a large base of sellers. The company develops leading local brands include Leboncoin in France, InfoJobs in Spain, Subito in Italy and Jofogás in Hungary. While Schibsted (SCHA NO) will remain majority ownership of Adevinta, Adevinta will spin off as an independent listed company.
See more details
Tufin Software (TRADING)
April 11, 2019
NYSE
TUFN US
Price Range: US$12.00 - US$14.00/share ***Priced at $14.00/share***
Shares Offered: 7,700,000 shares. ~23.7% float
Tufin Software Technologies is a cybersecurity software company incorporated in Israel in 2005. The company provides a policy-centric approach to unify security policy across IT and cloud environments. Tufin generates revenues from the sales of five software products (~50.07%) and through maintenance and other related professional services (~49.93%). The company has a P/S ratio of 5.34x.
Price Range: US$12.00 - US$14.00/share ***Priced at $14.00/share***
Shares Offered: 7,700,000 shares. ~23.7% float
Tufin Software Technologies is a cybersecurity software company incorporated in Israel in 2005. The company provides a policy-centric approach to unify security policy across IT and cloud environments. Tufin generates revenues from the sales of five software products (~50.07%) and through maintenance and other related professional services (~49.93%). The company has a P/S ratio of 5.34x.
See more details
Karnov Group (TRADING)
April 11, 2019
Stockholm Stock Exchange
KAR SS
***Price fixed at SEK 43.00/share***
Shares Offered: 43,513,472 shares (25,000,000 offered by selling shareholders) ~71.3% float
Karnov Group is a Denmark and Sweden rooted legal information services provider. Dated back to 1867, the company was involved in legal information publication, online legal research support and continued legal education business. Karnov was acquired by private equities throughout the years and was acquired by Five Arrows Principal Investment (owned by Rothchild) in 2015. Karnov provides online and offline information and workflow solutions in the areas of legal, tax and accounting, and environmental, healthy and safety. Current pricing gave Karnov an implied market cap of SEK 4.2 billion ($452.79 million). The Fourth Swedish National Pension Fund, Lazard Asset Management and Vind AS have agreed to purchase up to SEK 607.0 million from this offering (~14.5% of total outstanding shares).
***Price fixed at SEK 43.00/share***
Shares Offered: 43,513,472 shares (25,000,000 offered by selling shareholders) ~71.3% float
Karnov Group is a Denmark and Sweden rooted legal information services provider. Dated back to 1867, the company was involved in legal information publication, online legal research support and continued legal education business. Karnov was acquired by private equities throughout the years and was acquired by Five Arrows Principal Investment (owned by Rothchild) in 2015. Karnov provides online and offline information and workflow solutions in the areas of legal, tax and accounting, and environmental, healthy and safety. Current pricing gave Karnov an implied market cap of SEK 4.2 billion ($452.79 million). The Fourth Swedish National Pension Fund, Lazard Asset Management and Vind AS have agreed to purchase up to SEK 607.0 million from this offering (~14.5% of total outstanding shares).
See more details
PagerDuty (TRADING)
April 11, 2019
NYSE
PD US
Price Range: US$19.00 - US$21.00/share
***Amended Price Range $21.00 - $23.00/share***
***Priced at $24.00/share***
Shares Offered: 9,070,000 shares (570,000 shares from selling stockholders) ~11.55%
Founded in 2009, PagerDuty is a San Francisco-based digital services software company founded by three former Amazon developers. The company provides a platform that supports on-call management, modern incident management, and real-time operations for businesses. PagerDuty derive revenue from the sales of subscriptions to its On-Call Management platform. The company is valued at $1.5 billion with a P/S ratio of 13.12 x.
3 VC funds include Andreessen Horowitz and Accel Partners will be holding close to 40% shares after this offering.
Price Range: US$19.00 - US$21.00/share
***Amended Price Range $21.00 - $23.00/share***
***Priced at $24.00/share***
Shares Offered: 9,070,000 shares (570,000 shares from selling stockholders) ~11.55%
Founded in 2009, PagerDuty is a San Francisco-based digital services software company founded by three former Amazon developers. The company provides a platform that supports on-call management, modern incident management, and real-time operations for businesses. PagerDuty derive revenue from the sales of subscriptions to its On-Call Management platform. The company is valued at $1.5 billion with a P/S ratio of 13.12 x.
3 VC funds include Andreessen Horowitz and Accel Partners will be holding close to 40% shares after this offering.
See more details
Stadler Rail (TRADING)
April 12, 2019
SIX Swiss Exchange
SRAIL SW
Price Range: CHF 33.00 - 41.00/share
Shares Offered: 40,250,000 existing shares (with 35 million shares base offer held by Chairman Peter Spuhler) ~38.16% float
Dated back to 1942, Stadler is a Swiss train manufacturer. The company builds tailor-made trains from high-speed and intercity trains, suburban and regional transport trains, to light rail verticals and trams. Stadler also provides services from upgrading and overhaul to vehicle maintenance and repair. Stadler is valued at over 4 billion Swiss francs if priced on high-end. Spuhler will still hold close to 40% of Stadler after the offering. The funds from the IPO will flow into Spuhler's private holding PCS Holding to invest in Stadler Rail and other Spuhler's hodlings.
See more details
Jumia (TRADING)
April 12, 2019
NYSE
JMIA US (ADS)
Price Range: $13.00 - $16.00/share ***Priced at $14.5/share***
Shares Offered: 13,500,000 ADS (27,000,000 ordinary shares) ~17.6% float
Founded in 2012, Jumia Technologies (previously known as Africa Internet), is a Berlin, Germany-based e-commerce platform operator active in pan-African markets. The company provides an online marketplace with supporting logistics services and payment service. Africa's largest mobile network operator MTN Group and Germany-based venture capital company Rocket Internet are the two largest shareholders. Mastercard Europe has agreed to purchase €50.0 million ($56.01 million) of Jumia's shares in a concurrent private placement (~5% total shares). Jumia is valued at approximately $1.2 billion with a 8.02x P/S ratio.
Price Range: $13.00 - $16.00/share ***Priced at $14.5/share***
Shares Offered: 13,500,000 ADS (27,000,000 ordinary shares) ~17.6% float
Founded in 2012, Jumia Technologies (previously known as Africa Internet), is a Berlin, Germany-based e-commerce platform operator active in pan-African markets. The company provides an online marketplace with supporting logistics services and payment service. Africa's largest mobile network operator MTN Group and Germany-based venture capital company Rocket Internet are the two largest shareholders. Mastercard Europe has agreed to purchase €50.0 million ($56.01 million) of Jumia's shares in a concurrent private placement (~5% total shares). Jumia is valued at approximately $1.2 billion with a 8.02x P/S ratio.
See more details
Zengame Technology (TRADING)
April 16, 2019
Hong Kong Stock Exchange
2660 HK
Price Range: HK$1.12 - HK$1.32/share ***Priced at HK$1.23/share***
Shares Offered: 180,000,000 shares (~18% float)
Founded in 2010, Zengame is a Chinese mobile game developer and operator specializes on card and board mobile games. Zengame generates revenue from in-game advertisements and in-game virtual items' sales from both self-developed games (~98.9%) and third-party games (~1,1%). The most popular game in Zengame's pipeline contributes approximately 87% of its total game revenue. Cornerstone investor (Guotai Junan International) has agreed to purchase up to HK$20.0 million at offering.
Price Range: HK$1.12 - HK$1.32/share ***Priced at HK$1.23/share***
Shares Offered: 180,000,000 shares (~18% float)
Founded in 2010, Zengame is a Chinese mobile game developer and operator specializes on card and board mobile games. Zengame generates revenue from in-game advertisements and in-game virtual items' sales from both self-developed games (~98.9%) and third-party games (~1,1%). The most popular game in Zengame's pipeline contributes approximately 87% of its total game revenue. Cornerstone investor (Guotai Junan International) has agreed to purchase up to HK$20.0 million at offering.
See more details
Oragroup (TRADING)
April 16, 2019
BRVM Stock Exchange
Offer Price: fixed at 4,100.00 francs/share
Shares Offered: 6.1 million new share & 7.8 million exiting shares (~20% of its equity)
Oragroup is a pan-African bank operates in West and Central Africa. This is the largest IPO on Abidjan Stock Exchange (BRVM).
See more details
Nexi (TRADING)
April 16, 2019
Milan Stock Exchange
NEXI IM
Price Range: €8.50 - €10.35/share
Amended Price Range: €9.00 - €9.50/share ***Priced at €9.00/share***
Shares Offered: to sell minimum 213 million shares (~41.5% - 43.2% float) ***Upsized to 223 million shares***
Shares Offered: 213 millions shares (146 million offered by selling shareholders) ~41.5% float
Nexi (previously known as Istituto Centrale delle Branche Popolari or ICBPI) is a Milan, Italy-based payment processor. With more than 70 years of history working alongside with partner banks, the PayTech company operates in three market areas including merchant services and solutions, cards and digital payments and digital banking services. Nexi was sold to the private equity investors (Mercury UK, which is connected with funds managements by Bain Capital, Cleesidra Capital and Advent) in 2015 which valued the company at €2.15 billion. The current valuation indicates an approximately €7.1 to €8.1 billion EV, or a market capitalization of €5.4 - €6.4 billion. Nexi is expected to pay dividend.
See more details
Brainsway (TRADING)
April 17, 2019
NASDAQ GM
BWAY US (ADS)
*$11.00/share*
Shares Offered: 2,500,000 ADS ~23.1% float
The ordinary shares are listed on Tel Aviv Stock Exchange under the symbol BRIN
Brainsway is a commercial stage medical device company incorporated in Israel in 2006. The company develops and sells non-invasive neuromedolation products for the treatment of major depressive disorder and obsessive-compulsive disorder approved by the FDA. The two main products received clearance in 2013 and 2018 respectively. Brainsway will be trading at a P/S of 7.8x.
*$11.00/share*
Shares Offered: 2,500,000 ADS ~23.1% float
The ordinary shares are listed on Tel Aviv Stock Exchange under the symbol BRIN
Brainsway is a commercial stage medical device company incorporated in Israel in 2006. The company develops and sells non-invasive neuromedolation products for the treatment of major depressive disorder and obsessive-compulsive disorder approved by the FDA. The two main products received clearance in 2013 and 2018 respectively. Brainsway will be trading at a P/S of 7.8x.
See more details
Turning Point* (TRADING)
April 17, 2019
NASDAQ GM
TPTX US
Price Range: $16.00 - $18.00/share ***Priced at $18.00/share***
Shares Offered: 7,352,941 shares (~26% float) ***Upsized to offer 8,823.530 shares (~30.2% float)***
Founded in 2013, Turning Point Therapeutics is a San Diego, CA-based early clinical-stage biopharmaceutical company. The company targets cancer therapies, especially TKI therapy. Turning Point Therapeutics has a platform of TKI drug candidates address the treatment resistance and toxicities limitation of current TKI inhibitors. The lead drug candidate is under phase1/2 clinical trial. Existing shareholders have indicated an interest to purchase up to $50 million from this offering (close to 40% of the offer).
Price Range: $16.00 - $18.00/share ***Priced at $18.00/share***
Shares Offered: 7,352,941 shares (~26% float) ***Upsized to offer 8,823.530 shares (~30.2% float)***
Founded in 2013, Turning Point Therapeutics is a San Diego, CA-based early clinical-stage biopharmaceutical company. The company targets cancer therapies, especially TKI therapy. Turning Point Therapeutics has a platform of TKI drug candidates address the treatment resistance and toxicities limitation of current TKI inhibitors. The lead drug candidate is under phase1/2 clinical trial. Existing shareholders have indicated an interest to purchase up to $50 million from this offering (close to 40% of the offer).
See more details
Grupo SBF (TRADING)
April 17, 2019
B3 Day
CNTO3 BZ
Price Range: BRL12.10 - BRL 4.70/share ***Priced at 12.50 Brazilian Real/share***
Shares Offered: 53.7 million shares
Grupo SBF (Centauro) is a Brazil sporting goods retailer.
Price Range: BRL12.10 - BRL 4.70/share ***Priced at 12.50 Brazilian Real/share***
Shares Offered: 53.7 million shares
Grupo SBF (Centauro) is a Brazil sporting goods retailer.
See more details
Palomar (TRADING)
April 17, 2019
NASDAQ GS
PLMR US
Price Range: $15.00 - $17.00/share ***Priced at $15.00/share***
Shares Offered: 5,625,000 shares (~24.86% float)
Founded in 2014, Palomar is an insurance holding company located in La Jolla. The company provides specialty property insurance in markets for earthquake, wind and flood insurance. Palomar is majority owned by San Francisco based private equity firm Genstar Capital.
Price Range: $15.00 - $17.00/share ***Priced at $15.00/share***
Shares Offered: 5,625,000 shares (~24.86% float)
Founded in 2014, Palomar is an insurance holding company located in La Jolla. The company provides specialty property insurance in markets for earthquake, wind and flood insurance. Palomar is majority owned by San Francisco based private equity firm Genstar Capital.
See more details
HOOKIPA Pharma (TRADING)
April 18, 2019
NASDAQ GM
HOOK US
Price Range: $14.00 - $16.00/share ***Priced at $14.00/share***
Shares Offered: 6,666,667 shares (~25% float) ***Downsized to 6,000,000 shares***
HOOKIPA is a clinical-stage biopharmaceutical company with a focus on treatments for infectious diseases and cancers (immuno-oncology) based on a proprietary arenavirus platform. Founded in 2011 in Austria, HOOKIPA was incorporated in 2017, headquartered in New York with European research and preclinical development operations headquartered in Vienna Austria. The company has 6 product candidates in its pipeline with the most advanced lead product candidate in phase2 clinical trial and the rest all in preclinical stage. Hookipa has entered into a strategic partnership with Gilead to develop therapeutics to treat hepatitis B and HIV.
Price Range: $14.00 - $16.00/share ***Priced at $14.00/share***
Shares Offered: 6,666,667 shares (~25% float) ***Downsized to 6,000,000 shares***
HOOKIPA is a clinical-stage biopharmaceutical company with a focus on treatments for infectious diseases and cancers (immuno-oncology) based on a proprietary arenavirus platform. Founded in 2011 in Austria, HOOKIPA was incorporated in 2017, headquartered in New York with European research and preclinical development operations headquartered in Vienna Austria. The company has 6 product candidates in its pipeline with the most advanced lead product candidate in phase2 clinical trial and the rest all in preclinical stage. Hookipa has entered into a strategic partnership with Gilead to develop therapeutics to treat hepatitis B and HIV.
See more details
Pinterest* (TRADING)
April 18, 2019
NYSE
PINS US
Price Range: $15.00 - $17.00/share ***Priced at $19.00/share***
Shares Offered: 75,000,000 shares (~14% float of total Class A & B common stock outstanding)
Founded in 2008 as Cold Brew Labs, Pinterest is a San Francisco-based digital advertising platform. The company is valued up to $9.1 billion at current price range (excluding all stock options and shares reserved). The company generates revenue by delivering advertising on its website and mobile application on a cost per click (CPC) basis and a cost per thousand imppressions (CPM) basis. The company will be trading at a 10.5 - 12.2 P/S ratio.
Price Range: $15.00 - $17.00/share ***Priced at $19.00/share***
Shares Offered: 75,000,000 shares (~14% float of total Class A & B common stock outstanding)
Founded in 2008 as Cold Brew Labs, Pinterest is a San Francisco-based digital advertising platform. The company is valued up to $9.1 billion at current price range (excluding all stock options and shares reserved). The company generates revenue by delivering advertising on its website and mobile application on a cost per click (CPC) basis and a cost per thousand imppressions (CPM) basis. The company will be trading at a 10.5 - 12.2 P/S ratio.
See more details
Greenlane* (TRADING)
April 18, 2019
NASDAQ GM
GNLN US
Price Range: $14.00 - $16.00/share ***Priced at $17.00/share***
Shares Offered: 5,333,333 shares (4,666,666 new Class A common stock, 666,667 shares by selling stockholders) ***Upsized to 6,000,000 shares (5,250,000 new shares and 750,000 from selling stockholders)***
Founded in 2005, Boca Raton Florida-based Greenlane distributes vaporization products to wholesale and retail customers (smoke shops and regional retail chain stores) in both U.S. and Canada. The company also owns and operates two e-commerce sites that sells vaporizers and other related products (i.e. pipes, rolling papers etc.) The business is indirectly linked with the cannabis industry for its products can be used with cannabis or cannabis derivative. Products manufactured by JUUL represents over 1/3 of the net sale.
Price Range: $14.00 - $16.00/share ***Priced at $17.00/share***
Shares Offered: 5,333,333 shares (4,666,666 new Class A common stock, 666,667 shares by selling stockholders) ***Upsized to 6,000,000 shares (5,250,000 new shares and 750,000 from selling stockholders)***
Founded in 2005, Boca Raton Florida-based Greenlane distributes vaporization products to wholesale and retail customers (smoke shops and regional retail chain stores) in both U.S. and Canada. The company also owns and operates two e-commerce sites that sells vaporizers and other related products (i.e. pipes, rolling papers etc.) The business is indirectly linked with the cannabis industry for its products can be used with cannabis or cannabis derivative. Products manufactured by JUUL represents over 1/3 of the net sale.
See more details
Brigham Minerals* (TRADING)
April 18, 2019
NYSE
MNRL US
Price Range: $15.00 - $18.00/share ***Priced at $18.00/share***
Shares Offered: 13,500,000 Class A shares (~28.4% float of Class A & B common stock outstanding)
Formed in 2012, Brigham Minerals manages a portfolio of mineral and royalty interests across four U.S. basins with six resources plays. The company generates revenue from royalty payments based on the sales of oil, natural gas and NGLs produced from the acreage interests sold.
Price Range: $15.00 - $18.00/share ***Priced at $18.00/share***
Shares Offered: 13,500,000 Class A shares (~28.4% float of Class A & B common stock outstanding)
Formed in 2012, Brigham Minerals manages a portfolio of mineral and royalty interests across four U.S. basins with six resources plays. The company generates revenue from royalty payments based on the sales of oil, natural gas and NGLs produced from the acreage interests sold.
See more details
Zoom Video* (TRADING)
April 18, 2019
NASDAQ GM
ZM US
Price Range: $28.00 - $32.00/share
Amended Price Range $33.00 - $35.00/share ***Priced at $36.00/share***
Shares Offered: 20,869,565 shares (10,877,446 new share and 9,992,119 from selling stockholders, ~8% float of total Class A&B shares outstanding)
Founded in 2011 as Saasbee, Zoom Video Communications is a San Jose, CA-based company that provides a cloud-native video communication platform for meetings. Flagship products include Zoom Meetings, Zoom Rooms, and Zoom Phone that enable remote video and audio conferencing adopt by tech companies, hospitals and universities. Entities affiliated with Emerging Capital Partners, Sequoia Capital and some executive officers are among the selling stockholders. Salesforce has agreed to purchase $100 million from offering (~15%). The company is valued at over $8.35 billion, with a P/S of 25.3x. The company just turned a profit this fiscal year.
Price Range: $28.00 - $32.00/share
Amended Price Range $33.00 - $35.00/share ***Priced at $36.00/share***
Shares Offered: 20,869,565 shares (10,877,446 new share and 9,992,119 from selling stockholders, ~8% float of total Class A&B shares outstanding)
Founded in 2011 as Saasbee, Zoom Video Communications is a San Jose, CA-based company that provides a cloud-native video communication platform for meetings. Flagship products include Zoom Meetings, Zoom Rooms, and Zoom Phone that enable remote video and audio conferencing adopt by tech companies, hospitals and universities. Entities affiliated with Emerging Capital Partners, Sequoia Capital and some executive officers are among the selling stockholders. Salesforce has agreed to purchase $100 million from offering (~15%). The company is valued at over $8.35 billion, with a P/S of 25.3x. The company just turned a profit this fiscal year.
See more details
Al Moammar Information Systems (TRADING)
April 24, 2019
Saudi Stock Exchange
MIS AB
Fixed offer price at 45.00 Saudi Riyal
Shares Offered: 4.8 million shares ~30% float
Al Moammar Information Systems (MIS) is a Saudi based company focus on wholesale and retail of computer, electronic and telecommunication devices. The company also provides related installation and maintenance of electronic devices. The company is valued at 720 million Saudi Riyal at offer price, representing ~$192 million.
Fixed offer price at 45.00 Saudi Riyal
Shares Offered: 4.8 million shares ~30% float
Al Moammar Information Systems (MIS) is a Saudi based company focus on wholesale and retail of computer, electronic and telecommunication devices. The company also provides related installation and maintenance of electronic devices. The company is valued at 720 million Saudi Riyal at offer price, representing ~$192 million.
See more details
Shenwan Hongyuan (TRADING)
April 26, 2019
Hong Kong Stock Exchange
6806 HK (A+H share)
Price Range: HK$3.63 - HK$3.93/share ***Priced at HK$3.63/share***
Shares Offered: 2,504,000,000 H shares (~10.0% float of A+H Shares)
Shenwan Hongyuan is a Chinese financial service company focused on securities businesses in China. It is a product from the merger between Shenyin & Wanguo Securities and Hong Yuan Securities in 2015. The A Share of the company is listed on Shenzhen Stock Exchange (000166 SZ). Shenwan Hongyuan provides services in Enterprise Finance (Investment Banking, Principal Investment), Personal Finance, Institutional Services and Trading and Investment Management. Personal finance and institutional services and trading account for close to 80% of its total revenue. This will be the largest offering in Hong Kong this year.
Price Range: HK$3.63 - HK$3.93/share ***Priced at HK$3.63/share***
Shares Offered: 2,504,000,000 H shares (~10.0% float of A+H Shares)
Shenwan Hongyuan is a Chinese financial service company focused on securities businesses in China. It is a product from the merger between Shenyin & Wanguo Securities and Hong Yuan Securities in 2015. The A Share of the company is listed on Shenzhen Stock Exchange (000166 SZ). Shenwan Hongyuan provides services in Enterprise Finance (Investment Banking, Principal Investment), Personal Finance, Institutional Services and Trading and Investment Management. Personal finance and institutional services and trading account for close to 80% of its total revenue. This will be the largest offering in Hong Kong this year.
See more details
Loungers (TRADING)
April 29, 2019
London Stock Exchange
LGRS LN
Placing Price at 2.00 pound sterling/share
Placing Price at 2.00 pound sterling/share
See more details
TransMedics* (TRADING)
May 2, 2019
NASDAQ GM
TMDX US
Price Range: $15.00 - $17.00/share ***Priced at $16.00/share***
Shares Offered: 4,700,000 shares ~24.4% float
Dated back in 1998, TransMedics is a Andover, MA-based commercial-stage medical technology company focus on organ preservation for transplantation. The company developed and commercialized the Organ Care System (OCS) that indicates to prolong organ preservation for transplantation (organ cold storage). The company currently has three OCS products for lung, heart and liver transplantation respectively. The OCS Lungs and Heart are commercialized outside of the United States and OCS Lung has received a premarket approval from the FDA. The company is valued at ~$300 million and will be traded with a P/S of 25x.
Price Range: $15.00 - $17.00/share ***Priced at $16.00/share***
Shares Offered: 4,700,000 shares ~24.4% float
Dated back in 1998, TransMedics is a Andover, MA-based commercial-stage medical technology company focus on organ preservation for transplantation. The company developed and commercialized the Organ Care System (OCS) that indicates to prolong organ preservation for transplantation (organ cold storage). The company currently has three OCS products for lung, heart and liver transplantation respectively. The OCS Lungs and Heart are commercialized outside of the United States and OCS Lung has received a premarket approval from the FDA. The company is valued at ~$300 million and will be traded with a P/S of 25x.
See more details
So-Young International (TRADING)
May 2, 2019
NASDAQ GM
SY US (ADS)
Price Range: $11.80 - $13.80/share ***Priced at $13.8/share***
Shares Offered: 13,000,000 ADS (representing 10,000,000 Class A Ordinary Shares) ~13% float
Founded in 2013 in Beijing, So-Young operates a platform that provides medical aesthetic information in China. The company generates revenue from fees charged to partnered medical aesthetic service providers when users seek for information (67.3%) or make online reservation services for medical aesthetic treatment through the platform (32.7%). So-Young has a valuation of approximately $1.38 billion if priced on high-end at a 15.3x P/S ratio.
Price Range: $11.80 - $13.80/share ***Priced at $13.8/share***
Shares Offered: 13,000,000 ADS (representing 10,000,000 Class A Ordinary Shares) ~13% float
Founded in 2013 in Beijing, So-Young operates a platform that provides medical aesthetic information in China. The company generates revenue from fees charged to partnered medical aesthetic service providers when users seek for information (67.3%) or make online reservation services for medical aesthetic treatment through the platform (32.7%). So-Young has a valuation of approximately $1.38 billion if priced on high-end at a 15.3x P/S ratio.
See more details
Beyond Meat* (TRADING)
May 2, 2019
NASDAQ GM
BYND US
Price Range: $19.00 - $21.00/share
***Amended Price Range: $23.00 - $25.00/share*** ***Priced at $25.00/share***
Shares Offered: 8,750,000 shares ~15% float
Founded in 2011 as 'J Green Natural Foods' (later 'Savage River'), Beyond Meat is a VC-backed food company operates in the meat industry. The company produces and distributes plant-based meats products. Beyond Meat is valued at approximately $1.2 billion based on current offer price and will be trade at a 13.6x P/S. Tyson held a small stake in Beyond Meat but has quietly sold its position ahead of the final offering.
Price Range: $19.00 - $21.00/share
***Amended Price Range: $23.00 - $25.00/share*** ***Priced at $25.00/share***
Shares Offered: 8,750,000 shares ~15% float
Founded in 2011 as 'J Green Natural Foods' (later 'Savage River'), Beyond Meat is a VC-backed food company operates in the meat industry. The company produces and distributes plant-based meats products. Beyond Meat is valued at approximately $1.2 billion based on current offer price and will be trade at a 13.6x P/S. Tyson held a small stake in Beyond Meat but has quietly sold its position ahead of the final offering.
See more details
Red River Bancshares (TRADING)
May 3, 2019
NASDAQ GS
RRBI US
Price Range $42.00 - $46.00/share ***Priced at $45.00/share***
Shares Offered: 573,320 shares (26,680 shares from selling stockholders) ~7.85% float
Founded in 1998 and headquartered in Alexandria, Louisiana, Red River Bank is a regional state-chartered bank that provides banking services to commercial and retail customers. The Bank is paying a small amount of cash dividend.
Price Range $42.00 - $46.00/share ***Priced at $45.00/share***
Shares Offered: 573,320 shares (26,680 shares from selling stockholders) ~7.85% float
Founded in 1998 and headquartered in Alexandria, Louisiana, Red River Bank is a regional state-chartered bank that provides banking services to commercial and retail customers. The Bank is paying a small amount of cash dividend.
See more details
Yunji (TRADING)
May 3, 2019
NASDAQ GM
YJ US (ADS)
Price Range: $11.00 - $13.00/share ***Priced at $11.00/share***
Shares Offered: 13,500,000 ADS/135,000,000 Class A Share ~6.2% float of total Class A + B shares
***Downsized to 11,000,000 ADS***
Founded in 2015, Yunji operates a membership-based social e-commerce platform in China. The company primarily generates revenues from selling products on the platform (~87.5%) and membership subscription (~11.9%). Yunji also generates revenues on net basis from sales of certain products such as mobile phones, tickets to tourist attractions, bookings and car insurance policies. The company will be valued at over $2.8 billion on high-end and trade at a P/S of around 1.5x.
Price Range: $11.00 - $13.00/share ***Priced at $11.00/share***
Shares Offered: 13,500,000 ADS/135,000,000 Class A Share ~6.2% float of total Class A + B shares
***Downsized to 11,000,000 ADS***
Founded in 2015, Yunji operates a membership-based social e-commerce platform in China. The company primarily generates revenues from selling products on the platform (~87.5%) and membership subscription (~11.9%). Yunji also generates revenues on net basis from sales of certain products such as mobile phones, tickets to tourist attractions, bookings and car insurance policies. The company will be valued at over $2.8 billion on high-end and trade at a P/S of around 1.5x.
See more details
SciPlay* (TRADING)
May 3, 2019
NASDAQ GS
SCPL US
Price Range: $14.00 - $16.00/share ***Priced at $16.00/share***
Shares Offered: 22,000,000 Class A shares ~17% float pf total common stock (Class A + B) to be outstanding
Launched in 2012, SciPlay is a Las Vegas, NV-based mobile (and web) games developer and publisher. SciPlay launched its first game in 2012. The company is a spin-off from Scientific Games (SGMS US). SciPlay offers 7 core social casino games and casual games. The company generates revenue from the sale of in-game virtual coins and chips for the casino-style slot games.
SciPlay recorded a $416.2 million in revenue in 2018. The spin-off is expected to have a market capitalization up to $2.02 billion and trade at a P/E ratio over 30x.
Price Range: $14.00 - $16.00/share ***Priced at $16.00/share***
Shares Offered: 22,000,000 Class A shares ~17% float pf total common stock (Class A + B) to be outstanding
Launched in 2012, SciPlay is a Las Vegas, NV-based mobile (and web) games developer and publisher. SciPlay launched its first game in 2012. The company is a spin-off from Scientific Games (SGMS US). SciPlay offers 7 core social casino games and casual games. The company generates revenue from the sale of in-game virtual coins and chips for the casino-style slot games.
SciPlay recorded a $416.2 million in revenue in 2018. The spin-off is expected to have a market capitalization up to $2.02 billion and trade at a P/E ratio over 30x.
See more details
Duiba Group (TRADING)
May 7, 2019
Hong Kong Stock Exchange
1753 HK
Price Range: HK$6.00 - HK$8.10/share ***Priced at HK$6.00/share***
Shares Offered: 111,111,200 shares
Founded in 2011, Duibai Group provides a user management SaaS platform and an interactive advertising platform in China.
Price Range: HK$6.00 - HK$8.10/share ***Priced at HK$6.00/share***
Shares Offered: 111,111,200 shares
Founded in 2011, Duibai Group provides a user management SaaS platform and an interactive advertising platform in China.
See more details
SNK (TRADING)
May 7, 2019
KOSDAQ
950180 KS (Depositary Receipts)
Price Range: KRW30,800 - KRW40,400 ***Priced at 40,400 Korean won***
Shares Offered: 4.2 million shares
Founded in 1978, SNK is a Japanese game company famous for The King of Fighters game.
Price Range: KRW30,800 - KRW40,400 ***Priced at 40,400 Korean won***
Shares Offered: 4.2 million shares
Founded in 1978, SNK is a Japanese game company famous for The King of Fighters game.
See more details
Trevi Therapeutics (TRADING)
May 7, 2019
NASDAQ GM
TRVI US
Price Range: $14.00 - $16.00/share (Postponed, ***Priced at $10.00/share***)
Shares Offered: 4,666,667 shares ~30.2% float
***Amendment: upsized to 7 million shares***
***Amendment to 5.5 million shares***
Incorporated in 2011, Trevi Therapeutics is a New Haven, Connecticut-based VC-backed biopharmaceutical company. The company is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. The development is under the Phase 2b/3 clinical trial and is expected to submit a new drug application (NDA) later than 2020. Trevis has an exclusive license agreement with Endo Pharmaceuticals (ENDP US). Existing shareholders have indicated an interest in purchasing approximately $28.0 million (up to 43%) of the offering.
Price Range: $14.00 - $16.00/share (Postponed, ***Priced at $10.00/share***)
Shares Offered: 4,666,667 shares ~30.2% float
***Amendment: upsized to 7 million shares***
***Amendment to 5.5 million shares***
Incorporated in 2011, Trevi Therapeutics is a New Haven, Connecticut-based VC-backed biopharmaceutical company. The company is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. The development is under the Phase 2b/3 clinical trial and is expected to submit a new drug application (NDA) later than 2020. Trevis has an exclusive license agreement with Endo Pharmaceuticals (ENDP US). Existing shareholders have indicated an interest in purchasing approximately $28.0 million (up to 43%) of the offering.
See more details
China Everbright Water (TRADING)
May 8, 2019
Hong Kong Stock Exchange
1857 HK (Dual Primary Listing)
Price Range: HK$2.99 - HK$4.35 ***Priced at HK$2.99/share***
Shares Offered: 103,970,000 shares
China Everbright Water is trading on Singapore Exchange (SGX-ST Main Board) under the CEWL SP since 2004.
Price Range: HK$2.99 - HK$4.35 ***Priced at HK$2.99/share***
Shares Offered: 103,970,000 shares
China Everbright Water is trading on Singapore Exchange (SGX-ST Main Board) under the CEWL SP since 2004.
See more details
Parsons* (TRADING)
May 8, 2019
NYSE
PSN US
Price Range: $26.00 - $28.00/share ***Priced at $27.00/share***
Shares Offered: 18,518,000 shares ~19.1% float
Founded in 1944, Parsons provides technology solutions (technical design and engineering services and software) focuses on the defense, intelligence and critical infrastructure markets. Parsons generates revenues from two segment, 1) Federal Solutions (41.5%) which provides the U.S. government and its agencies with services in cybersecurity, missile defense systems, military training, subsurface munitions detection, military facility modernization, logistics support, chemical weapon remediation and engineering services; 2) Critical Infrastructure (58.5%) with both federal, state, municipal and industry customers. The company is valued at approximately $2.7 billion if priced on high-end, with a EPS of $2.78, i.e. a P/E ratio of 10.1x.
Price Range: $26.00 - $28.00/share ***Priced at $27.00/share***
Shares Offered: 18,518,000 shares ~19.1% float
Founded in 1944, Parsons provides technology solutions (technical design and engineering services and software) focuses on the defense, intelligence and critical infrastructure markets. Parsons generates revenues from two segment, 1) Federal Solutions (41.5%) which provides the U.S. government and its agencies with services in cybersecurity, missile defense systems, military training, subsurface munitions detection, military facility modernization, logistics support, chemical weapon remediation and engineering services; 2) Critical Infrastructure (58.5%) with both federal, state, municipal and industry customers. The company is valued at approximately $2.7 billion if priced on high-end, with a EPS of $2.78, i.e. a P/E ratio of 10.1x.
See more details
NextCure (TRADING)
May 9, 2019
NASDAQ GM
NXTC US
Price Range: $14.00 - $16.00/share ***Priced at $15.00/share***
Shares Offered: 5,000,000 shares ~22.8% float
Founded in 2015, NextCure is an early clinical-stage biopharmaceutical company focuses on cancer and other immune-related diseases treatment. NextCure has its most advanced product candidate, a monoclonal antibody targeting tumors in Phase 1 clinical study. The company has a multi-year collaboration agreement with Eli Lilly for one of its discovery/preclinical phase pipeline program. Pfizer holds ~10% of NextCure. Existing stockholders have indicated an interest in purchasing approximately $35 million of shares in this offering (~43.75%).
Price Range: $14.00 - $16.00/share ***Priced at $15.00/share***
Shares Offered: 5,000,000 shares ~22.8% float
Founded in 2015, NextCure is an early clinical-stage biopharmaceutical company focuses on cancer and other immune-related diseases treatment. NextCure has its most advanced product candidate, a monoclonal antibody targeting tumors in Phase 1 clinical study. The company has a multi-year collaboration agreement with Eli Lilly for one of its discovery/preclinical phase pipeline program. Pfizer holds ~10% of NextCure. Existing stockholders have indicated an interest in purchasing approximately $35 million of shares in this offering (~43.75%).
See more details
HeadHunter* (TRADING)
May 9, 2019
NASDAQ GS
HHR US (ADS)
Price Range: $11.00 - $13.50/share ***Priced at $13.50/share***
Shares Offered: 16,304,348 ADS ~32.6% float
Founded in 2000, HeadHunter Group is a online recruitment platform in Russia and the Commonwealth of Independent States (CIS). HeadHunter generates revenues from its subscription-based services (including access to its resume/CV database or bundle subscriptions) (55% of total revenue), job posting fees, and other value added services. Current price range gives HHR a market capitalization of $675.0 million on high-end, a 7.13 P/S ratio and an EPS of approximately $0.29 (18.99 Russian Ruble).
Price Range: $11.00 - $13.50/share ***Priced at $13.50/share***
Shares Offered: 16,304,348 ADS ~32.6% float
Founded in 2000, HeadHunter Group is a online recruitment platform in Russia and the Commonwealth of Independent States (CIS). HeadHunter generates revenues from its subscription-based services (including access to its resume/CV database or bundle subscriptions) (55% of total revenue), job posting fees, and other value added services. Current price range gives HHR a market capitalization of $675.0 million on high-end, a 7.13 P/S ratio and an EPS of approximately $0.29 (18.99 Russian Ruble).
See more details
Axcella Health* (TRADING)
May 9, 2019
NASDAQ GM
AXLA US
Price Range: $20.00 - $22.00/share ***Priced at $20.00/share***
Shares Offered: 3,571,428 shares ~15.5% float
Founded in 2008 as Newco LS16 in Cambridge, MA, Axcella Health is an pre-clinical early-stage biotech company. The company has a pipeline comprises five programs focused on the metabolic functions of liver, muscle and blood (with 6 drug candidates). The most advanced product candidate is anticipated to enroll in clinical trial in late 2020.
Price Range: $20.00 - $22.00/share ***Priced at $20.00/share***
Shares Offered: 3,571,428 shares ~15.5% float
Founded in 2008 as Newco LS16 in Cambridge, MA, Axcella Health is an pre-clinical early-stage biotech company. The company has a pipeline comprises five programs focused on the metabolic functions of liver, muscle and blood (with 6 drug candidates). The most advanced product candidate is anticipated to enroll in clinical trial in late 2020.
See more details
Viva Biotech (TRADING)
May 9, 2019
Hong Kong Stock Exchange
1873 HK
Price Range: HK$3.42 - HK$4.41/share ***Priced at HK$4.41/share***
Shares Offered: 345,000,000 shares, ~22% float
Founded in 2008, Shanghai-based Viva Biotech provides structure-based drug discovery services to biotech and pharmaceutical companies worldwide.
Price Range: HK$3.42 - HK$4.41/share ***Priced at HK$4.41/share***
Shares Offered: 345,000,000 shares, ~22% float
Founded in 2008, Shanghai-based Viva Biotech provides structure-based drug discovery services to biotech and pharmaceutical companies worldwide.
See more details
Cortexyme (TRADING)
May 9, 2019
NASDAQ GS
CRTX US
Price Range: $16.00 - $18.00/share ***Priced at $17.00/share***
Shares Offered: 4,412,000 shares ~17.0% float
Founded in 2012, South San Francisco-based Cortexyme is a clinical stage biopharmaceutical company focused on Alzheimer's and other degenerative diseases. Cortexyme has four programs in the early phase of development but only has one lead product candidate COR388 in Phase 2/3 trial (with a FDA partial hold). The company has an impressive list of strategic investors, including Pfizer, Takeda, Verily Life Sciences and Sequoia Capital. Existing stockholders have indicated an interest in purchasing up to $35 million of shares offered (~44% of the offer)
Price Range: $16.00 - $18.00/share ***Priced at $17.00/share***
Shares Offered: 4,412,000 shares ~17.0% float
Founded in 2012, South San Francisco-based Cortexyme is a clinical stage biopharmaceutical company focused on Alzheimer's and other degenerative diseases. Cortexyme has four programs in the early phase of development but only has one lead product candidate COR388 in Phase 2/3 trial (with a FDA partial hold). The company has an impressive list of strategic investors, including Pfizer, Takeda, Verily Life Sciences and Sequoia Capital. Existing stockholders have indicated an interest in purchasing up to $35 million of shares offered (~44% of the offer)
See more details
Milestone Pharmaceuticals* (TRADING)
May 9, 2019
NASDAQ GM
MIST US
Price Range: $14.00 - $16.00/share ***Priced at $15.00/share***
Shares Offered: 5,000,000 shares ~21.6% float ***Upsized to 5,500,000 shares***
Founded in 2003, Milestone Pharmaceuticals is a Canadian late clinical-stage biopharmaceutical company. Milestone focuses on a rapid-onset and short acting calcium channel blocker called Etripamil and has three product candidates in pipeline with its lead product candidate for rapid termination treatment of PSVT, a rapid cardiac condition, in Phase 3 clinical trial.
Price Range: $14.00 - $16.00/share ***Priced at $15.00/share***
Shares Offered: 5,000,000 shares ~21.6% float ***Upsized to 5,500,000 shares***
Founded in 2003, Milestone Pharmaceuticals is a Canadian late clinical-stage biopharmaceutical company. Milestone focuses on a rapid-onset and short acting calcium channel blocker called Etripamil and has three product candidates in pipeline with its lead product candidate for rapid termination treatment of PSVT, a rapid cardiac condition, in Phase 3 clinical trial.
See more details
Mayville Engineering (TRADING)
May 9, 2019
NYSE
MEC US
Price Range: $19.00 - $21.00/share ***Priced at $17.00/share***
Shares Offered: 6,250,000 shares ~31.7% float
Founded in 1945, Mayville Engineering (MEC) is an engineered component supplier/fabricator to original equipment manufacturer (OEM) in the United States. Heavy-and medium-duty commercial vehicles, construction, powersports, agriculture and military are the five major end markets MEC focused on. John Deere is one of MEC's biggest customers. MEC has a market capitalization of approximately $413.6 million if priced on high-end.
Price Range: $19.00 - $21.00/share ***Priced at $17.00/share***
Shares Offered: 6,250,000 shares ~31.7% float
Founded in 1945, Mayville Engineering (MEC) is an engineered component supplier/fabricator to original equipment manufacturer (OEM) in the United States. Heavy-and medium-duty commercial vehicles, construction, powersports, agriculture and military are the five major end markets MEC focused on. John Deere is one of MEC's biggest customers. MEC has a market capitalization of approximately $413.6 million if priced on high-end.
See more details
ARA US Hospitality Trust (TRADING)
May 9, 2019
Singapore Exchange
HOTEL SP (Unit)
Fixed Price at $0.88/unit
ARA Group spin-off its US hotels portfolio under the Hyatt brand.
ARA US Hospitality Trust is the first hospitality trust on SGX purely on the US market.
Fixed Price at $0.88/unit
ARA Group spin-off its US hotels portfolio under the Hyatt brand.
ARA US Hospitality Trust is the first hospitality trust on SGX purely on the US market.
See more details
South Plains Financial (TRADING)
May 9, 2019
NASDAQ GS
SPFI US
Price Range: $17.50 - $19.50/share ***Priced at $17.50/share***
Shares Offered: 3,380,000 shares (2,700,000 new shares, 680,000 shares from selling shareholder) ~19.35% float
South Plains Financial is a Texas-based regional bank. Through City Bank, its wholly-owned subsidiary, the group provides commercial and consumer financial services to small and medium-sized businesses and individuals across Texas and New Mexico.
Price Range: $17.50 - $19.50/share ***Priced at $17.50/share***
Shares Offered: 3,380,000 shares (2,700,000 new shares, 680,000 shares from selling shareholder) ~19.35% float
South Plains Financial is a Texas-based regional bank. Through City Bank, its wholly-owned subsidiary, the group provides commercial and consumer financial services to small and medium-sized businesses and individuals across Texas and New Mexico.
See more details
Sonim Technologies (TRADING)
May 10, 2019
NASDAQ GM
SONM US
Price Range: $13.00 - $15.00/share ***Priced at $11.00/share***
Shares Offered: 3,571,429 shares, ~18.3% float
Founded in 1999 as NaviSpin.com in San Mateo, CA, Sonim Technologies provides ultra--rugged mobile phones and accessories designed specifically for task workers (workers in industrial enterprise and public sector). The company generates revenue from master sales arrangements with channel partners (i.e. AT&T, Sprint and Verizon) as well as non-recurring engineering services (design services).
Price Range: $13.00 - $15.00/share ***Priced at $11.00/share***
Shares Offered: 3,571,429 shares, ~18.3% float
Founded in 1999 as NaviSpin.com in San Mateo, CA, Sonim Technologies provides ultra--rugged mobile phones and accessories designed specifically for task workers (workers in industrial enterprise and public sector). The company generates revenue from master sales arrangements with channel partners (i.e. AT&T, Sprint and Verizon) as well as non-recurring engineering services (design services).
See more details
Jiayin Group (TRADING)
May 10, 2019
NASDAQ GM
JFIN US (ADS)
Price Range: $10.50 - $12.50/share ***Priced at $10.50/share***
Shares Offered: 3.5 million ADS
Price Range: $10.50 - $12.50/share ***Priced at $10.50/share***
Shares Offered: 3.5 million ADS
See more details
Life360 (TRADING)
May 10, 2019
Australian Securities Exchange
360 AU (CDI, CHESS Depositary instruments)
Price Range: AU$ 4.79 - AU$5.26/share ***Priced at AU$4.79/share***
Shares Offered: 21.4 - 23.5 million CDIs
Founded in 2008, Life360 is a U.S. startup that develops and operates a family tracking mobile app. The social networking app allows family members to track each other and share each other's location. The company is valued at $689.2 million to $745.8 million based on current pricing. This would be the largest tech IPO in Australia since 2016.
Price Range: AU$ 4.79 - AU$5.26/share ***Priced at AU$4.79/share***
Shares Offered: 21.4 - 23.5 million CDIs
Founded in 2008, Life360 is a U.S. startup that develops and operates a family tracking mobile app. The social networking app allows family members to track each other and share each other's location. The company is valued at $689.2 million to $745.8 million based on current pricing. This would be the largest tech IPO in Australia since 2016.
See more details
Uber* (TRADING)
May 10, 2019
NYSE
UBER US
Price Range: $44.00 - $50.00/share ***Priced at $45.00/share***
Shares Offered: 180,000,000 shares, ~10.7% float
PayPal has agreed to purchase $500 million in a private placement. Current price range indicates a $84 billion valuation, a 30% cut from its previous $120 billion valuation.
Price Range: $44.00 - $50.00/share ***Priced at $45.00/share***
Shares Offered: 180,000,000 shares, ~10.7% float
PayPal has agreed to purchase $500 million in a private placement. Current price range indicates a $84 billion valuation, a 30% cut from its previous $120 billion valuation.
See more details
Applied Therapeutics* (TRADING)
May 14, 2019
NASDAQ GM
APLT US
Price Range: $14.00 - $16.00/share ***Priced at $10.00/share***
Shares Offered: 4,000,000 shares ~23.5% float
Applied Therapeutics is a New York, NY-based clinical-stage biopharmaceutical company founded in 2016. The lead product candidate is developed for the treatment of diabetic cardiomyopathy ant other diabetic related diseases. Applied Therapeutics has 6 product candidates in pipeline with the most advanced program in phase 2/3 clinical trial. The company has all its current product candidates' associated IP rights licensed from Columbia University.
Price Range: $14.00 - $16.00/share ***Priced at $10.00/share***
Shares Offered: 4,000,000 shares ~23.5% float
Applied Therapeutics is a New York, NY-based clinical-stage biopharmaceutical company founded in 2016. The lead product candidate is developed for the treatment of diabetic cardiomyopathy ant other diabetic related diseases. Applied Therapeutics has 6 product candidates in pipeline with the most advanced program in phase 2/3 clinical trial. The company has all its current product candidates' associated IP rights licensed from Columbia University.
See more details
ConversionPoint (POSTPONED)
May 14, 2019
NASDAQ CM
CPTI US
Price Range: $6.00 - $7.00/share
Shares Offered: 6,153,846 shares ~21.85% float
ConversionPoint is a combined company of ConversionPoint and Inuvo. The company provides e-commerce marketing and management supports.
Price Range: $6.00 - $7.00/share
Shares Offered: 6,153,846 shares ~21.85% float
ConversionPoint is a combined company of ConversionPoint and Inuvo. The company provides e-commerce marketing and management supports.
See more details
Frequentis (TRADING)
May 14, 2019
Frankfurt Stock Exchange
FQT GR
Price Range: €18.00 - €21.00/share ***Priced at €18.00/share***
Shares Offered: 3 million shares (1.2 million new shares)
Founded in 1947 to rebuild broadcast communication in war torn Vienna, Frequentis provides voice communication and information management and networking solutions to support land, sea, air and space control center operations. Austrian trust B&C agreed to purchase 10% shares in a private placement.
Price Range: €18.00 - €21.00/share ***Priced at €18.00/share***
Shares Offered: 3 million shares (1.2 million new shares)
Founded in 1947 to rebuild broadcast communication in war torn Vienna, Frequentis provides voice communication and information management and networking solutions to support land, sea, air and space control center operations. Austrian trust B&C agreed to purchase 10% shares in a private placement.
See more details
Postal Realty Trust (TRADING)
May 15, 2019
NYSE
PSTL US (REIT)
Price Range: $19.00 - $21.00/share ***Priced at $17.00/share***
Shares Offered: 5,000,000 shares ***Downsized to 4,500,000 shares***
The corporation owns and manages a portfolio of 271 postal properties lease to the United States Postal Service (USPS) and provides fee-based third party property management services for an additional 404 postal proprieties leased to the USPS.
Price Range: $19.00 - $21.00/share ***Priced at $17.00/share***
Shares Offered: 5,000,000 shares ***Downsized to 4,500,000 shares***
The corporation owns and manages a portfolio of 271 postal properties lease to the United States Postal Service (USPS) and provides fee-based third party property management services for an additional 404 postal proprieties leased to the USPS.
See more details
Finablr (TRADING)
May 15, 2019
London Stock Exchange
FIN LN
Price Range: 210.0 pence - 260.0 pence/share ***Price at 175.00 pence/share***
Price Range: 210.0 pence - 260.0 pence/share ***Price at 175.00 pence/share***
See more details
PIMCO Mortgage Income Trust* (POSTPONED)
May 16, 2019
NYSE
PMTG US
Fixed price at $20.00/share
Shares Offered: 50,000,000 shares
PMTG is a newly organized real estate finance company externally managed and advised by PIMCO. The company intends to acquire, manage and finance Agency RMBS (residential mortgage backed security), MSRs (mortgage servicing rights), Non-Agency RMBS, residential mortgage loans and other real estate-related assets.
Fixed price at $20.00/share
Shares Offered: 50,000,000 shares
PMTG is a newly organized real estate finance company externally managed and advised by PIMCO. The company intends to acquire, manage and finance Agency RMBS (residential mortgage backed security), MSRs (mortgage servicing rights), Non-Agency RMBS, residential mortgage loans and other real estate-related assets.
See more details
SAI Leisure (TRADING)
May 16, 2019
Hong Kong Stock Exchange
1832 HK
Price Range: HK$3.54 - HK$4.48/share ***Priced at HK$3.54/share***
Shares Offered: 90,000,000 shares, 25% float
S.A.I. Leisure is a leisure tourism group began in 1997. The group operates hotels and resorts in Saipan and Guam in the U.S. Island territories.
Price Range: HK$3.54 - HK$4.48/share ***Priced at HK$3.54/share***
Shares Offered: 90,000,000 shares, 25% float
S.A.I. Leisure is a leisure tourism group began in 1997. The group operates hotels and resorts in Saipan and Guam in the U.S. Island territories.
See more details
Leong Hup International (TRADING)
May 16, 2019
Bursa Malaysia
LHIB MK
Price Range: MYR 1.09 - MYR 1.10/share ***Priced at MYR1.10/share***
Established in 1960s and headquartered in Malaysia, Leong Hup International operates in livestock feed production, poultry farming and poultry products in South East Asia region.
Price Range: MYR 1.09 - MYR 1.10/share ***Priced at MYR1.10/share***
Established in 1960s and headquartered in Malaysia, Leong Hup International operates in livestock feed production, poultry farming and poultry products in South East Asia region.
See more details
Luckin Coffee (TRADING)
May 17, 2019
NASDAQ GM
LK US (ADS)
Price Range: $15.00 - $17.00/share ***Priced at $17.00/share***
Shares Offered: 30,000,000 ADSs (equivalent to 240,000,000 ordinary shares) ~12.9% float
***Upsized to 33,000,000 ADSs***
Commenced operation in late 2017, Luckin Coffee is a fast-growing Chinese coffee network. The company provides coffee and other products through both mobile app and store network. Louis Dreyfus Company B.V. has agreed to purchase $50.0 million of the offering. Luckin Coffee is valued at close to $4.0 billion.
Price Range: $15.00 - $17.00/share ***Priced at $17.00/share***
Shares Offered: 30,000,000 ADSs (equivalent to 240,000,000 ordinary shares) ~12.9% float
***Upsized to 33,000,000 ADSs***
Commenced operation in late 2017, Luckin Coffee is a fast-growing Chinese coffee network. The company provides coffee and other products through both mobile app and store network. Louis Dreyfus Company B.V. has agreed to purchase $50.0 million of the offering. Luckin Coffee is valued at close to $4.0 billion.
See more details
Fastly (TRADING)
May 17, 2019
NYSE
FSLY US
Price Range: $14.00 - $16.00/share ***Priced at $16.0/share***
Shares Offered: 11,250,000 shares ~12.4% float (total Class A & B stocks)
Founded in 2011 under the name SkyCache, Fastly is a San Francisco, CA-based Content Delivery Network (CDN) provider. The company provides a cloud platform for developers for both established enterprises and tech companies. Fastly is valued up to $1.45 billion with a P/S ratio of approximately 10x.
Price Range: $14.00 - $16.00/share ***Priced at $16.0/share***
Shares Offered: 11,250,000 shares ~12.4% float (total Class A & B stocks)
Founded in 2011 under the name SkyCache, Fastly is a San Francisco, CA-based Content Delivery Network (CDN) provider. The company provides a cloud platform for developers for both established enterprises and tech companies. Fastly is valued up to $1.45 billion with a P/S ratio of approximately 10x.
See more details
Avantor* (TRADING)
May 17, 2019
NYSE
AVTR US
Price Range: $18.00 - $21.00/share ***Priced at $14.00/share***
***Amended Price Range: $14.00 - $15.00/share***
Shares Offered: 154,000,000 shares (100 shares from selling stockholder) ~36.11% float
***Upsized to 205,000,000 shares, ~39.0% float***
Originated from J.T. Baker Chemical Company in 1904, Avantor was bought by private equity (New Mountain Capital, Raj Gupta) from Covidien in 2010 and grew through a series of acquisitions including two high-profiled deal with NuSil and VWR. Avantor was incorporated in 2017 after the M&A with VWR. Avantor provides materials & consumables, equipment & instrumentation, and services & specialty procurement for biopharma, healthcare, education & goverment, and advanced technologies & applied materiel industries. The offering proceeds will be mainly used to repay outstanding indebtedness. Goldman Sachs will receive approximately 12.5% of the net proceeds of this offering as it to cash out Avantor's senior preferred stock. This is the second largest IPO in the U.S. this year. The lab equipment/special material and chemical maker is valued at close to $9.0 billion if priced on high-end, exclude all debts with a P/S ratio close to 1.5x.
Broad Street Principal Investments, L.L.C. (“BSPI”), a current investor, has indicated an interest in purchasing an aggregate of up to $150 million in common stock in this offering at the initial public offering price.
Price Range: $18.00 - $21.00/share ***Priced at $14.00/share***
***Amended Price Range: $14.00 - $15.00/share***
Shares Offered: 154,000,000 shares (100 shares from selling stockholder) ~36.11% float
***Upsized to 205,000,000 shares, ~39.0% float***
Originated from J.T. Baker Chemical Company in 1904, Avantor was bought by private equity (New Mountain Capital, Raj Gupta) from Covidien in 2010 and grew through a series of acquisitions including two high-profiled deal with NuSil and VWR. Avantor was incorporated in 2017 after the M&A with VWR. Avantor provides materials & consumables, equipment & instrumentation, and services & specialty procurement for biopharma, healthcare, education & goverment, and advanced technologies & applied materiel industries. The offering proceeds will be mainly used to repay outstanding indebtedness. Goldman Sachs will receive approximately 12.5% of the net proceeds of this offering as it to cash out Avantor's senior preferred stock. This is the second largest IPO in the U.S. this year. The lab equipment/special material and chemical maker is valued at close to $9.0 billion if priced on high-end, exclude all debts with a P/S ratio close to 1.5x.
Broad Street Principal Investments, L.L.C. (“BSPI”), a current investor, has indicated an interest in purchasing an aggregate of up to $150 million in common stock in this offering at the initial public offering price.
See more details
Medialink
May 21, 2019
Hong Kong Stock Exchange
2230 HK
Price Range: HK$0.45 - HK$0.53/share ***Priced at HK$0.45/share***
Shares Offered: 498,000,000 shares, ~25% float
Medialink is a media content distributor. Headquartered in Hong Kong, the 18-year-old third-party owned media content distributor has presence in the Asia Pacific region. Medialink generates revenue from media content distribution (93%) and brand licensing (7%).
Price Range: HK$0.45 - HK$0.53/share ***Priced at HK$0.45/share***
Shares Offered: 498,000,000 shares, ~25% float
Medialink is a media content distributor. Headquartered in Hong Kong, the 18-year-old third-party owned media content distributor has presence in the Asia Pacific region. Medialink generates revenue from media content distribution (93%) and brand licensing (7%).
See more details
Arabian Centres
May 22, 2019
Saudi Arabia
ALMRAKEZ AB
Price Range: SAR 26.00 - SAR 33.00/share
Price Range: SAR 26.00 - SAR 33.00/share
See more details
Rattler Midstream*
May 23, 2019
RTLR US (Common Unit)
Price Range: $16.00 - $19.00/common unit
Shares Offered: 33,333,333 units
Price Range: $16.00 - $19.00/common unit
Shares Offered: 33,333,333 units
See more details
Peloton Therapeutics
May 23, 2019
NASDAQ GS
PLTX US
Price Range: $15.00 - $17.00/share
Shares Offered: 9,375,000 shares, ~21.1% float
Founded in 2010 under the name 'Damascus Pharmaceutics', Peloton Therapeutics is a Dallas, Texas-based clinical stage biopharmaceutical company focused on cancer treatment.
Price Range: $15.00 - $17.00/share
Shares Offered: 9,375,000 shares, ~21.1% float
Founded in 2010 under the name 'Damascus Pharmaceutics', Peloton Therapeutics is a Dallas, Texas-based clinical stage biopharmaceutical company focused on cancer treatment.
See more details
Ideaya Biosciences
May 23, 2019
NASDAQ GM
IDYA US
Price Range: $13.00 - $15.00/share
Shares Offered: 5,000,000 shares, ~25.67% float
Founded in 2015, South San Francisco, CA-based Ideaya Biosciences is a oncology-focused precision medicine company. Ideaya currently has 4 product candidate with the most advanced product candidate in Phase 1 clinical trial. The product candidate is obtained from Novartis.
Price Range: $13.00 - $15.00/share
Shares Offered: 5,000,000 shares, ~25.67% float
Founded in 2015, South San Francisco, CA-based Ideaya Biosciences is a oncology-focused precision medicine company. Ideaya currently has 4 product candidate with the most advanced product candidate in Phase 1 clinical trial. The product candidate is obtained from Novartis.
See more details
Bicycle Therapeutics*
May 23, 2019
NASDAQ GM
BCYC US (ADS)
Price Range: $14.00 - $16.00/share
Shares Offered: 4,333,333 shares, ~24.5% float
Founded in 2009 in England, Bicycle Therapeutics is a early clinical-stage biopharmaceutical company primarily focused on oncology. The company currently has 4 preclinical/phase I products in its pipeline with the most advanced product candidate fully funded by the Centre for Drug Development of Cancer Research UK. Bicycle also collaborates with several large pharmaceutical companies including AstraZeneca, Bioverativ, Dementia Discovery Fund, and Oxurion. Existing shareholders have indicated an interest in purchase up to $25.0 million in this offering (~36%). Bicycle Therapeutics has a star founding team including Christian Heinis, John Tite, and Nobel prize winner Sir Greg Winter.
Price Range: $14.00 - $16.00/share
Shares Offered: 4,333,333 shares, ~24.5% float
Founded in 2009 in England, Bicycle Therapeutics is a early clinical-stage biopharmaceutical company primarily focused on oncology. The company currently has 4 preclinical/phase I products in its pipeline with the most advanced product candidate fully funded by the Centre for Drug Development of Cancer Research UK. Bicycle also collaborates with several large pharmaceutical companies including AstraZeneca, Bioverativ, Dementia Discovery Fund, and Oxurion. Existing shareholders have indicated an interest in purchase up to $25.0 million in this offering (~36%). Bicycle Therapeutics has a star founding team including Christian Heinis, John Tite, and Nobel prize winner Sir Greg Winter.
See more details
Eagle Hospitality Trust (POSTPONED)
May 24, 2019
Singapore
EAGLEHT SP
Priced at US$0.78/unit
Priced at US$0.78/unit
See more details
Mulsanne Group
May 27, 2019
HKEX
1817 HK
Price Range: HK$4.68 - HK$5.88/share
Shares Offered: 200,000,000 shares, ~21% float
Mulsanne is a fashion menswear company based in China.
Price Range: HK$4.68 - HK$5.88/share
Shares Offered: 200,000,000 shares, ~21% float
Mulsanne is a fashion menswear company based in China.
See more details
New Fortress Energy
January 31, 2020
NASDAQ
NFE US
fixed price offer at $15/share, 20.0 million shares
downsized, below range
See more details
Disclaimer:
The IPOX Deal Calendar may not provide a complete list of all global initial public offerings (IPOs). Deals presented are subject to minimum market capitalization requirement and minimum deal size requirement. Companies pursing an IPO on Over-The-Counter (OTC) markets, best efforts offerings, closed-end fund (CEF), special purpose acquisition companies (SPAC), mainland China stock (A share) and Indian stocks are not included. Please refer to the Legal Disclaimer.
